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 Porphyromonas gingivalis, a gram-negative anaerobic bacterium, is a major 
etiological agent in the initiation and progression of severe forms of periodontal disease. 
Oral bacteria like P. gingivalis are subject to continually changing conditions as a 
consequence of host eating, oral hygiene patterns and subgingival temperatures. As such 
survival requires an adaptive response to environmental cues, but little is known about 
the mechanism by which P. gingivalis controls co- and post-transcriptional regulation of 
RNA levels and potentially protein expression. RNA-binding proteins  (RBPs) are 
evolutionarily conserved across species and are involved in such regulatory mechanisms. 
However, P. gingivalis currently has no identified RBP. Recently, PG0627 has become 
an ideal candidate for a putative RBP due to its sequence homology to RBPs across 
various species. By characterizing PG0627, we can gain better insight into the function of 
 iv 
 
this hypothetical protein and determine if it indeed behaves like an RNA-binding protein. 
A host of studies were done on a PG0627-deficient P. gingivalis mutant, V3139, in order 
to determine the biological role of the protein encoded by the gene. Our bioinformatics 
analysis indicated that PG0627 had sequence homology to several RNA recognition 
motifs or RBPs. Furthermore, our PG0627-deficient mutant, when compared to W83, 
exhibited decreased cell-associated iron content, decreased total interactions and 
invasions with eukaryotic cells, and decreased protease activity. Conversely, our 
PG0627-deficient mutant displayed slightly increased growth in the presence of 
nitrosative stress, and in hemin-depleted conditions. In conclusion, our results support 
that PG0627 is a valid candidate for an RNA-binding protein in P. gingivalis. 
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Chapter 1: INTRODUCTION 
  
 
1.1 Periodontal Disease 
 
1.1.1 General 
Periodontal diseases are chronic inflammatory diseases affecting the well-
vascularized connective tissues that comprise the supporting tissues of the teeth (Chapple 
et al., 2000). These diseases range in severity from mild and reversible inflammation of 
the gingiva to progressive destruction of periodontal ligament and alveolar bone, 
eventually leading to tooth loss (Lamont and Jenkinson, 1998). Periodontal diseases are 
very prevalent with an estimated 50% of adults in the US that have experienced some 
form of the disease, though less than 10% have the severe forms (Lamont and Jenkinson, 
2010). Of the worldwide population, an estimated 300 million are believed to be affected 
by the disease (Pihlstrom et al., 2005; Wayakanon et al., 2013). 
 
1.1.2 Initiation and Progression 
 The initiation of periodontitis begins with an accumulation of dental plaque below 
the gum line in the gingival crevice and on teeth (Figure 1). Dental plaque is made up of 
a microbial biofilm of over 700 different bacterial species, ranging from commensal to 
potentially virulent organisms (Rylev and Kilian, 2008). These organisms are highly-
evolved and highly-specialized, having adapted survival strategies favoring growth in the 
oral cavity (Darveau and Page, 2000). A dynamic equilibrium exists between normal 
bacterial oral flora and the innate host defense system, and a diseased state is likely due 
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to an imbalance of the two (Darveau, 2010). The ability of a pathogen to colonize and 
proliferate within a particular environmental niche in the host is essential for the initiation 
of an infection. Growth depends, in part, on the ability of a pathogen to scavenge 
essential nutrients. 
Microbiological analyses have shown that the composition of commensal oral 
bacteria isolated from healthy sites is significantly different from those isolated from 
diseased sites. The microbial load was found to be low in healthy sites (102-103 isolates 
from individual sulcus), consisting mostly of gram-positive bacteria with about 15% 
gram-negative rod species (Darveau and Page, 2000). Conversely, characterization of the 
periopathogenic microbial flora revealed a higher microbial load (105-108 isolates from 
individual pockets), with 15-50% of isolates being gram-negative (Darveau and Page, 
2000; Tanner et al., 1996). Severe forms of periodontal disease in adults are known to be 
associated with an increased number of gram-negative anaerobic bacteria (Lamont and 
Jenkinson, 1998). These findings are all in line with the temporally distinct patterns of 
microbial colonization within the oral cavity (Aas et al., 2005). The initial colonizers of 
the dental plaque biofilm are principally oral streptococci and actinomyces (Hasegawa et 
al., 2007). Establishment of these organisms facilitates the subsequent colonization of 
additional actinomyces and related gram-positive rods along with gram-negative bacteria. 
Further maturation is characterized by colonization by gram-negative anaerobes, such as 
Porphyromonas gingivalis (Kolenbrander et al., 2000; Rosan and Lamont, 2000). Once 
colonization of the subgingival area has occurred, organisms that shed from the plaque 
biofilm can interact with host epithelial cells that both have a barrier function and act as 
sensors of microbial infection (Ismail and Hooper, 2005). While many common oral 
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organisms can adhere to gingival epithelial cells, only a subset of these organisms, 
particularly P. gingivalis, can invade host cells (Lamont and Jenkinson, 1998; Tribble et 
al., 2006) and possess a remarkable array of virulence factors (Lamont and Yilmaz, 
2000), including immune response suppressors, proteolytic enzymes that degrade host 
tissues and adherence factors that promote bacterial survival (Jandik, 2008). 
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Figure 1. Pathogens involved in the progression of periodontitis shed from biofilm 
aggregated on tooth enamel and proceed to invade host cells. Adapted from 
http://drjerrypaz.files.wordpress.com/2011/03/tooth_anatomy_overview.jpg. 
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1.1.3 Prevention and Treatment 
 Prevention of periodontal diseases is based on controlling the causal or risk 
factors, with the most widely accepted risk factor being the biofilm that forms on the 
teeth in the absence of effective oral hygiene (Pihlstrom et al., 2005). However, various 
other host factors have also been shown to play a role in the initiation and progression of 
periodontal diseases and are important considerations in the prevention and treatment of 
periodontitis, including smoking, tobacco use, pregnancy, puberty, genetics, obesity, poor 
nutrition, psychosocial stress, depression and systemic diseases such as diabetes (Lamont 
and Jenkinson, 2000; LeResche and Dworkin, 2002; Pihlstrom et al., 1980). 
 Oral hygiene procedures such as tooth brushing and flossing are the primary form 
of prevention of biofilm buildup. Use of mouthwashes and dentrifices containing 
antibacterial drugs can reduce biofilm and are generally not associated with the 
emergence of a resistant microbiota (Sreenivasa and Gaffar, 2002). However, once all 
healthy oral hygiene procedures are ceased, the biofilm begins to develop on the teeth 
within 24 hours and causes gingivitis in 10-21 days (Loe et al., 1965). When this occurs, 
the primary treatment of periodontal disease is then through anti-infective non-surgical 
treatment aimed at controlling the biofilm. Dental plaque and calculus can be removed 
from tooth-crown and root surfaces through scaling and root planning. Supplemental use 
of local antibiotics, local antiseptic drugs, systemic antibiotics and systemic use of sub-
antimicrobial low-dose doxycycline have been shown to provide some additional benefit 
compared to debridement alone (Haffajee et al., 2003; Hanes and Purvis, 2003; Hung and 
Douglass, 2002; Preshaw et al., 2004). Furthermore, nitro-imidazoles, tetracyclines and 
azithromycin are used most often for antibiotic therapy for anaerobic bacteria like P. 
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gingivalis (Mombelli and Samaranayake, 2004). However, this therapy poses a problem. 
Though antibiotics can penetrate human tissue, they transverse the plasma membrane of 
human cells very poorly. Thus, the bacteria that reside intracellularly such as P. 
gingivalis are protected from antimicrobial activity and can subsequently escape from 
their host cell to re-establish infection and disease (Wayakanon et al., 2013). 
 Given this escape mechanism of P. gingivalis, much is being done to study the 
various virulence factors of the bacteria as an alternative target for therapy. 
 
1.2 Porphyromonas gingivalis 
Porphyromonas gingivalis, a gram-negative anaerobe, is a major etiological agent 
in the initiation and progression of severe forms of periodontal disease (Lamont and 
Jenkinson, 1998). This bacterium is non-motile, asaccharolytic and rod-shaped with over 
2000 known genes and exhibits smooth, raised colonies. When grown on blood agar 
plates, the colonies progress from an initially creamy-white color to black after 7-10 
days, which correlates with the concentration of protoheme (Murakami et al., 2004).  
In addition to being a major culprit in periodontal disease, P. gingivalis is also 
implicated as an accessory factor in certain systemic conditions, including increased risk 
of atherosclerotic heart disease and aspiration pneumonia (Seymour et al., 2007), pre-
term delivery, stroke, and diabetes (Boston University Medical Center, 2011). Despite 
these epidemiological associations, the mechanisms for the various relationships remain 
unknown, but current hypotheses postulate an interplay between common susceptibility, 
systemic inflammation with increased circulating cytokines and mediators, direct 
infection and cross-reactivity or molecular mimicry (Seymour et al., 2007). 
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This pathogen is perhaps the most intensively studied oral organism at the 
molecular level and its pathogenicity is attributed to a panel of potential virulence factors. 
 
1.2.1 Virulence Factors 
 Virulence is defined as the relative capacity of a microbe to cause disease or 
interfere with a metabolic or physiological function of a host, and virulence factors are 
thus molecules or components of a microbe that are capable of harming the host (Holt 
and Ebersole, 2005; Poulin and Combes, 1999; Slots, 1999). Porphyromonas gingivalis 
produces a large number of these enzymes, proteins and end-products of their metabolism 
that are active against a broad spectrum of host proteins and provide mechanisms not 
only for host invasion but also for evasion of host defenses (Holt et al., 1999). These 
latter compounds include proteinase inhibitors, immunoglobulins, iron-containing 
proteins, bactericidal proteins, extracellular matrix proteins, and proteins involved in 
phagocytic functions, such as complement fixation and coagulation (Potempa et al., 
1995). Conversely, virulence factors considered to be of importance in host invasion 
include the capsule, lipopolysaccharides (LPS), extracellular/surface cysteine proteases, 
and fimbriae (Hajishengallis, 2009; Lamont and Jenkinson, 1998).  
 The capsule of P. gingivalis forms the outermost layer of the bacteria, thereby 
protecting it from the host immune response and promoting its survival (Singh et al., 
2011). Separate studies have revealed that encapsulated P. gingivalis strains exhibit 
increased virulence as well as decreased phagocytosis when compared to non-
encapsulated strains (Grenier and Mayrand, 1987; Singh et al., 2011; Van Steenbergen et 
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al., 1987). The capsule has also been implicated in down-regulation of pro-inflammatory 
cytokine production (Brunner et al., 2010). 
The outer membrane of most gram-negative bacteria contains a major surface 
component called lipopolysaccharides or LPS. P. gingivalis can release copious amounts 
of outer membrane vesicles containing LPS, which can then penetrate periodontal tissue 
and participate in the destructive innate host response associated with disease (Grenier 
and Mayrand, 1987; Grenier et al., 1995; McCoy et al., 1987; Moore et al., 1986; 
Schwartz et al., 1972). LPS plays a critical role in mediating inflammation and inducing 
cells to secrete pro-inflammatory cytokines, particularly interleukin-1β (IL-1β), tumor 
necrosis factor-α (TNF-α) and IL-6. Most gram-negative LPS are known to stimulate the 
production of pro-inflammatory cytokines mainly through toll-like receptor (TLR) 4 and 
nuclear factor-κB (NF-κB) while most gram-positive peptidoglycan and lipopeptides use 
the TLR2 receptor (Darveau et al., 2004). However, P. gingivalis LPS-induced cytokine 
production has been elucidated to signal through both TLR4 and the TLR2 (Zhang et al., 
2008). 
 Fimbriae are adhesive hair-like appendages emanating from the bacterial cell 
surface. They are involved in cellular attachment, and mediate adhesion and invasion into 
host epithelial cells (Holt et al., 1999). Fimbriae have also been reported to induce the 
expression of inflammatory cytokines in human gingival fibroblasts and mouse peritoneal 
macrophages, strongly suggesting that fimbriae play a crucial role in bacterial interactions 
with host gingival tissues (Hanazawa et al., 1991; Murakami et al., 1994; Ogawa et al., 
1994). 
 
 9 
 
 
1.2.1.1 Cysteine Proteases 
 One of the potentially significant virulence characteristics of P. gingivalis is the 
large number of hydrolytic enzymes that are produced, specifically the gingipains. 
Gingipains are major cysteine proteases found in P. gingivalis and consist of lysine (Lys-
X) and arginine (Arg-X) specific proteases. They cleave after lysine and arginine residues 
and are encoded for by three genes: kgp for Lys-X, and rgpA and rgpB both coding for 
Arg-X (Okamoto et al., 1995; Okamoto et al., 1996). These extracellular proteases are 
believed to play a major role in the pathogenesis of periodontal disease as they are able to 
degrade a variety of host proteins which can serve as a source of nutrients, as well as 
have the potential to deregulate host defense (Travis et al., 1997). Specifically, these 
proteases can directly degrade host tissue, activate host pro-enzymes, neutralize the host 
immune response, degrade immunoglobulins, inactivate cytokines and their receptors, 
increase vascular permeability and promote bleeding (Kuramitsu et al., 1995). Moreover, 
the hemagglutinin/adhesion domain of these enzymes, which is similar to the P. 
gingivalis HagA hemagglutinin, has been shown to possess hemagglutinin activities and 
thus aid in hemin acquisition from hemoglobin molecules in erythrocytes (Curtis et al., 
1996; Han et al., 1996; Pike et al., 1996; Sroka et al., 2001). 
 
1.2.2 Predicted Mechanism of Invasion 
 Entry of P. gingivalis into gingival epithelial cells, which are nonprofessional 
phagocytic cells, is rapid and requires the bacteria and host cells to be metabolically 
active (Yilmaz et al., 2006). P. gingivalis’ adherence to and invasion of epithelial cells 
are triggered primarily by the binding of major fimbriae to β1 integrin receptors (Yilmaz 
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et al., 2002). The invasion strategy is accompanied by the phosphorylation and activation 
of putative integrin-signaling and structural proteins as well as by significant remodeling 
of the actin cytoskeleton, suggesting that rearrangements of the host cell signaling 
proteins permit bacterial entry into epithelial cells (Yilmaz et al., 2002; Yilmaz et al., 
2003). P. gingivalis is nonmotile in the extracellular space, invades epithelial cells in high 
numbers and is then localized to the cytoplasm (Belton et al., 1999). In vitro, the 
bacterium is capable of intracellular replication and remains viable for extended periods 
in epithelial cells. Likewise, invaded epithelial cells do not die and are anti-apoptotic and 
thus further contribute to the survival of P. gingivalis in the host (Yilmaz et al., 2006). 
 
1.2.3 Host Response 
 Once the pathogen has invaded the host, the body’s immune system fights the 
bacteria, releasing cytokines and chemokines thereby initiating the immune response as 
seen in Figure 2 (Bainbridge et al., 2010). However, this results in inflammation and bone 
resorption as the immune response actively combats the bacteria. If the condition is not 
treated, bones, gums and connective tissue are destroyed and teeth may have to be 
removed (Rylev and Kilian, 2008). 
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Figure 2. Porphyromonas gingivalis-induced dysbiosis and periodontal disease. 
Porphyromonas gingivalis subverts complement and impairs host defense, leading to 
overgrowth of oral commensal bacteria, which causes complement-dependent 
inflammation. Adapted from “The Keystone-Pathogen Hypothesis” by Hajishengallis et. 
al. 2012, http://www.nature.com/nrmicro/journal/v10/n10/fig_tab/nrmicro2873_F2.html    
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1.2.4 Role of Iron 
 P. gingivalis, like most living organisms, has an obligate iron requirement for 
growth and survival, yet the bacterium does not produce the essential nutrient itself 
(Lamont and Jenkinson, 1998). While many microorganisms have developed diverse and 
elaborate systems to obtain this element, including the production of siderophores which 
chelate environmental iron, P. gingivalis employs no such mechanism in iron-limited 
host environments (Bramanti and Holt, 1991; Genco, 1995; Schifferle et al., 1996). 
Instead, it scavenges iron from the host organism in the form of hemoglobin (Genco and 
Dixon, 2001). Heme is preferentially obtained from hemoglobin and is acquired through 
the activity of the cell surface Arg- and Lys-specific proteinase-adhesin complexes 
(Dashper et al., 2004; Shi et al., 1999; Shizukuishi et al., 1995). Hemoglobin released by 
lysis of erythrocytes is rapidly bound by haptoglobin and similarly, hemin is complexed 
to hemopexin (Lewis et al., 1999). As both of these compounds can be used as iron 
sources by P. gingivalis, this indicates that this bacterium has a mechanism for removing 
the hemin from these host iron-binding proteins (Bramanti and Holt, 1991). Although P. 
gingivalis is capable of utilizing various hemin-containing compounds, Shizukuishi et al. 
have shown that this organism utilizes hemoglobin more efficiently than other iron-
containing compounds (Bramanti and Holt, 1991; Genco, 1995; Shizukuishi et al., 1995). 
On P. gingivalis, acquired hemin is stored on the cell surface, a feature considered 
to give rise to the characteristic black-pigmented appearance of its colonies (Genco, 
1995). The intact hemin molecule (Figure 3) can be transported into the bacterium in an 
energy-dependent process regulated by the levels of available hemin, and specific 
 13 
 
interactions between the protoporphyrin IX ring and outer membrane proteins appear to 
initiate the uptake process (Bramanti and Holt, 1991; Genco et al., 1994). 
In the oral cavity itself, the levels of hemin are likely to show variance based on 
genetics, nutrient intake and other factors. Bleeding as a result of gingival inflammation 
can elevate subgingival hemin concentrations and may be one factor that predisposes a 
site to P. gingivalis accumulation (Lamont and Jenkinson, 1998). P. gingivalis has also 
developed mechanisms that will increase the availability of hemin such as the proteolytic 
activity of the cysteine proteases discussed previously. 
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Figure 3. Schematic of heme molecule utilized by P. gingivalis, iron-protoporphyrin IX. 
Abstracted from Wikipedia Commons. 
(http://upload.wikimedia.org/wikipedia/commons/thumb/b/be/Heme_b.svg/1000px-
Heme_b.svg.png) 
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1.2.5 Oxygen 
 Although P. gingivalis is an anaerobic bacterium, it does possess a low tolerance 
to oxygen and could thus be classified as an aerotolerant anaerobe (Diaz et al., 2002). 
That is, while it is incapable of colony formation on plates incubated aerobically, it can 
tolerate, for a limited time, the presence of atmospheric oxygen and it will grow in the 
presence of oxygen concentrations lower than that in air (Diaz and Rogers, 2004). During 
colonization of the oral tissues, P. gingivalis is exposed to various oxidative stress 
conditions, including saliva, the tongue, and the buccal mucosa (Dahlen et al., 1992; 
Lamont and Jenkinson, 2000; Van Steenbergen et al., 1993). This exposure leads to the 
presence of an unfavorable redox potential, and the damaging effects of reactive oxygen 
species (ROS) might challenge the bacterium’s survival before finding the appropriate 
anaerobic microenvironment in which to establish itself and proliferate (Diaz and Rogers, 
2004). The growth of P. gingivalis under oxygenated environments is also accompanied 
by changes in fermentation end-products, cell morphology, anti-oxidant enzymes and 
proteinase activity (Diaz and Rogers, 2004). Given these factors, it is essential for P. 
gingivalis to develop efficient oxidative stress protection mechanisms in order to survive 
oxygen exposure, but the mechanism is not currently well established.  
 
1.2.6 Nitrogen 
 Although P. gingivalis is dependent on nitrogenous substrates for energy, it must 
also be able to withstand the high concentrations of nitrite/nitric oxide that are 
particularly high in the oral cavity, thanks in part to high dietary nitrate intake (Shah and 
Gharbia, 1989). Nitric oxide is a highly reactive and cytotoxic free radical that can react 
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with oxygen and other molecules to result in the formation of toxic reactive nitrogen 
species (Hochgrafe, 2008). 
Following intake of foods rich in sucrose, the pH in the oral cavity drops 
drastically due to metabolic conversions of the sugar to acid, thus creating conditions that 
are favorable for the chemical generation of nitric oxide from nitrite (Lewis et al., 2012; 
Palmerini et al., 2003). Nitric oxide may also be generated from nitrite during metabolism 
through the respiratory nitrite reductase system, NrfHA (Spiro, 2006). However, a third 
source may come from host eukaryotic cells that respond to microbial infection by 
producing nitric oxide and 02-related species in the innate immune response (Fang, 1997). 
Despite these high concentrations of nitrite/nitric oxide in the oral cavity, little is 
known about the mechanism by which P. gingivalis tolerates nitrosative stress and 
detoxifies nitrite/nitric oxide. 
 
1.2.7 Regulation by RBPs 
 Oral bacteria, including P. gingivalis, are subject to continually changing 
conditions as a consequence of host eating, oral hygiene patterns and subgingival 
temperatures (Lamont and Jenkinson, 1998). As such survival requires an adaptive 
response to environmental cues, but little is known about the mechanism by which P. 
gingivalis controls co- and post-transcriptional regulation of RNA levels and potentially 
protein expression. RNA-binding proteins  (RBPs) are evolutionarily conserved across 
species and are involved in such regulatory mechanisms. However, P. gingivalis 
currently has no identified RBP. Recently, PG0627 has become an ideal candidate for a 
putative RBP due to its sequence homology to RBPs across various species. 
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 One such RBP is Hfq which is common to diverse bacterial lineages and has key 
roles in the control of gene expression. This protein is active co- and post-
transcriptionally, and serves several purposes in the cell. First, Hfq can suppress protein 
synthesis by aiding a sRNA to bind the 5’ region of its target mRNA, thus rendering the 
5’ region inaccessible for translation initiation (Vogel and Luisi, 2011). Conversely, it 
can boost translation by guiding an sRNA to the 5’ region of its target mRNA in order to 
disrupt a secondary structure that otherwise inhibits ribosome binding (Vogel and Luisi, 
2011). Additionally, Hfq can protect sRNAs from ribonuclease cleavage or present some 
RNAs in such a way as to promote RNA turnover by rendering the 3’ ends accessible for 
polyadenylation and subsequent 3’-to-5’ exonucleolytic degradation (Vogel and Luisi, 
2011). 
 A second protein which seems to share a great deal of protein sequence homology 
is a H. sapiens Cleavage stimulation factor 64kDA, particularly the N-terminal RRM 
recognition motif (for short, CstF-64). CstF-64 directly interacts with single-stranded 
RNAs via its RNA recognition motif (RRM) and plays important roles in mRNA 3’ 
processing (Chan et al., 2011; Takagaki et al., 1996). This protein binds a wide range of 
G/U-rich sequences on ssRNA with comparable affinity, yet is not highly specific for any 
one target sequence (Canadillas and Varani, 2003). Thus, much like that of RBPs, it 
displays slow kinetics and has the ability to bind tightly to a class of sequences without 
strong preference for any particular sequence, yet it can discriminate effectively against 
other RNAs. RBPs are known to bind to various motifs and ribosomal binding sites in 
order to instill their effect in degrading or stabilizing RNA, as well as inhibiting or 
stabilizing translation as stated previously. 
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1.2.8 PG0627 
 Due to its strong protein sequence homology to cross-species RBPs, and in 
particular, the N-terminal RRM of CstF-64, PG0627 was chosen as a candidate gene for a 
putative RNA-binding protein in P. gingivalis (Tables 1 and 2). If this is confirmed, it 
would be the first RBP elucidated in this oral bacterium. 
 PG0627 is defined as a putative RBP according to the Los Alamos National 
Laboratory P. gingivalis database (Los Alamos National Security, LLC, 2010). It is 
located in the cytoplasm, has a molecular weight of 11.5kDa, a gene length of 291bp and 
is composed of 96 amino acids (Figure 4). 
 
 
 
 
 
 
 
Figure 4. Locus of PG0627 in the P. gingivalis genome. As is seen here, the gene 
comprises a single transcriptional unit, color-coded in orange. 
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Table 1. Nucleotide sequence similarities of PG0627 to RBP sequences in other genes. 
 
Nucleotide Sequence 
Organism PG0627 Residues Protein Similarity 
Treponema pallidum 1-76 Putative RBP (gbAAC65342.1) 
53% 
 
Synechocystis sp. 3-76 RBP (gbAAA85379.1) 54% 
Brugia malayi 1-76 Putative RBP (gbAAC47624.1) 50% 
 
 
 
 
 
 
 
Table 2. Protein sequence similarity of PG0627 to proteins present in other proteins. 
 
Protein Sequence 
Organism Protein E-value Similarity 
Homo sapiens 
N-terminal RRM domain of Cleavage 
stimulation factor 64KDa subunit  
(PDB: 1P1T) 
6.3E12 62% 
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1.2.9 Other Genes of Interest 
 Four other genes of interest that are thought to help P. gingivalis adapt to 
environmental cues include, PG0893, PG1421, PG1820, and PG1821. 
 PG0893 is a hybrid cluster protein (Hcp) that is thought to protect P. gingivalis 
from exposure to nitric oxide by converting NO to other forms. PG1421 is a ferredoxin, 
which is an iron-sulfur protein that can change the oxidation state of iron by mediating 
electron transfer in redox reactions. PG1820 (NrfA) and PG1821 (NrfH) are both part of 
the cytochrome c nitrite reductase system. This subunit spans the periplasm (NrfA) and 
inner membrane (NrfH) and is thought to convert nitrite into ammonia thus playing a role 
in detoxification of nitrosative stress. Taken together, these four genes are thought to be 
part of the nitrosative stress protection mechanism network in P. gingivalis. 
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1.3 Research Objectives 
Hypothesis: 
We believe that P. gingivalis candidate proteins RBP (PG0627), NrfA (PG1820), 
NrfH (PG1821), Hcp (PG0893) and ferrodoxin (PG1421), may be involved in adaptation 
of P. gingivalis to environmental conditions. 
 
Aim 1: As P. gingivalis has been known to respond to environmental cues, we believe 
that PG0627, a putative RNA-binding protein, may play a role in altering RNA levels by 
degrading or stabilizing the RNA itself, or altering protein levels. Thus, it is significant to 
characterize the biological role of the putative RBP-deficient mutant, via: 
I. Bioinformatics 
II. Metal Content Assays 
III. Growth Studies 
a. Hemin Depletion 
b. Nitrosative Stress 
IV. Oxidative Stress 
V. Protease Activity Assays 
VI. Total Interactions and Invasions in Eukaryotic Cells 
VII. Gene Expression 
VIII. Proteomics 
   
Aim 2:  Although P. gingivalis is dependent on nitrogenous substrates for energy, it must 
also be able to withstand the high levels of nitrosative stress that are particularly high in 
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the oral cavity. Homologous sequences and products across other species of the four 
genes listed below were shown to be readily involved in nitrosative stress protection 
mechanisms, and for that reason have been studied here. Thus, the aim is to create mutant 
knockout strains deficient in the following genes in order to investigate their role in 
protection from nitrosative stress: PG0893, PG1421, PG1820, PG1821. This is being 
studied via: 
I. Generation of PCR Fusion Products 
II. Ligation, Cloning into pCR 2.1 TA Vector 
III. Electroporation 
IV. Mutant Confirmation 
V. Phenotypic Assessment of Mutant’s Ability to Survive Under Nitrosative 
Stress 
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Chapter 2: MATERIALS AND METHODS 
 
 
2.1 Bacterial Strains and Plasmids 
 
               The bacterial strains and plasmids used in this study are listed in Table 3. 
 
 
 
 
 
 
  
Table 3. Strains and plasmids used in this study 
 
 
 
Bacterial 
Species Strain Plasmid Description Reference 
P. gingivalis W83 Parental Strain  
 
Lewis and 
Macrina, 1999 
 
 V3139 
PG0627  
(RBP-deficient 
mutant) 
 Lewis et al. (unpublished) 
 
E. coli One Shot
® Top 
10 cells 
Chemically 
competent cells  
 
Invitrogen 
(Catalog 
Number: 
C404003) 
 
 
E. coli  pCR®2.1 
 
PCR TA 
cloning vector 
 
 
Invitrogen 
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2.2 Media Growth Conditions 
2.2.1 Porphyromonas gingivalis 
Porphyromonas gingivalis strains were grown in brain heart infusion broth (BHI; 
Difco Laboratories, Detroit, MI) supplemented with hemin (5µg/ml; Sigma-Aldrich, St. 
Louis, MO), yeast extract (5mg/ml; Sigma-Aldrich, St. Louis, MO), vitamin K 
(0.5µg/ml; Sigma-Aldrich, St. Louis, MO), and L-cysteine (1mg/mL; Sigma-Aldrich, St. 
Louis, MO). The P. gingivalis strains were grown anaerobically in a chamber at an 
atmosphere of 10% CO2, 10% H2,, 80% N2 at 37°C. 
 
2.2.2 Escherichia coli 
Escherichia coli was grown aerobically at 37 °C in Luria-Bertani broth (LB; 
Invitrogen; Cat. No. 12780029) or on LB agar. Kanamycin (50 µg/mL) was added to 
select for recombinant strains. 
 
2.3 Porphyromonas gingivalis Cell Culture Preparation 
P. gingivalis parental and mutant strains were spread onto blood agar plates (TSA II, 
5% sheep blood; BBL, Cockeysville, MD) with clindamycin (0.5 µg/ml) and grown 
anaerobically at 37°C. Once colonies were observed on the plates (3-7 days), a sterile 
inoculating loop was used to scoop the colonies, inoculate into BHI medium and grow at 
37°C. The cultures were diluted nearly daily to ensure that bacteria stayed in the log 
phase of growth until ready for harvesting. Once the cultures reached an optical density 
(OD660) of 0.5-0.7, they were ready for further use.  
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2.4 Generation of P. gingivalis Mutant Strains 
 Four potential mutant strains, ΔPG0893, ΔPG1421, ΔPG1820 and ΔPG1821, 
were generated for the purpose of characterization in P. gingivalis. A fusion PCR 
technique was used to generate these mutants where the upstream and downstream gene 
fragments and the selective cassette were first amplified separately by PCR using primers 
that produced overlapping ends (Cha-aim et al., 2012; Ho et al., 1989; Szewczyk et al., 
2006). A second PCR round then used primers to fuse the fragments together in the 
desired order, essentially replacing the gene with the selective cassette without the use of 
any restriction enzymes, and creating a knockout. All genes were amplified using 
Platinum® Taq DNA Polymerase High Fidelity kit (Invitrogen; Carlsbad, CA). All PCR 
purifications of the PCR products were done using the MiniElute PCR Purification kit 
(Qiagen; Valencia, CA). 
 
2.4.1 Isolation of ermF cassette 
 
 The ermF cassette is an 800 bp gene and was used as a selection factor for the 
mutant strains. It encodes resistance to erythromycin, and in anaerobic conditions, to 
clindamycin. It was isolated from the pVA2198 plasmid containing the 2 kb ermF-
ermAM antibiotic resistant gene cassette (Fletcher et al., 1995). It was thus used as the 
template DNA to amplify the ermF cassette using primers ermFF and ermFR, and then 
purified (Table 4). 
 
2.4.2 Generation of PCR Products 
 Fusion PCR techniques were used to generate linear PCR products without the 
use of restriction enzymes, creating a knockout of each gene (Cha-aim et al., 2012; Ho et 
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al., 1989; Szewczyk et al., 2006). 250-300 bp upstream and downstream homologous 
flanking regions of the target genes were amplified using P. gingivalis W83 genomic 
DNA as a template and then purified. In the first PCR round, the flanking regions of the 
target region were amplified using the primers in Table 4, e.g. 1820F1-1820R1 primers 
and 1820F2-1820R2 primers (Integrated DNA Technologies; Coralville, IA). The 
primers 1820F2 and 1820R2 were designed so that the amplification products generated 
had sequences homologous to the ends of the ermF cassette (also Table 4). The fragments 
generated from the first round of PCR as well as the ermF fragment were then used as 
templates for the second round of PCR, in which, for example, 1820F1 and 1820R2 
primers were used to create a linear product suitable for transformation (Figure 5). This 
was done using the Gibson Assembly Master Mix per manufacturer’s instructions (NEB, 
Cat. No. E2611L). Gibson Assembly efficiently joins multiple overlapping DNA 
fragments in a single-tube isothermal reaction, regardless of fragment length or end 
compatibility. The same two-step PCR process was done for genes PG0893, PG1421 and 
PG1821. The conditions used in the PCR reactions were: 1) one cycle of denaturing at 
94°C for 5 minutes, 2) 35 cycles of denaturing at 94°C for 2 minutes and annealing at 
53°C for 30 seconds, 3) elongation at 68°C for 3 minutes, and 4) final extension at 68°C 
for 7 minutes. The fused products were then confirmed via gel electrophoresis. 
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Table 4. Primers used for fusion PCR for PG0893, PG1421, PG1820, PG1821 and ermF.  
 
* Tails, in blue, were added to create homologous flanking regions to the gene, in black. 
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Figure 5. Schematic diagram of two rounds of fusion PCR used to generate linear fused 
gene products of PG0893, PG1421, PG1820 and PG1821. PG1820 and ermF were used 
as a specific example. 
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2.4.3 PCR Purification 
 After gel confirmations, PCR products were purified using the MiniElute PCR 
Purfication Kit using manufacturer’s instructions (Qiagen; Cat. No. 28006). 
 
2.5 Cloning and Transformation 
 Once the desired PCR fragments were produced, the products were individually 
cloned into the pCR® 2.1 vector (Figure 6) and transformed into One Shot® TOP10 
Chemically Competent E. coli cells using manufacturer’s instructions (TA Cloning® Kit; 
Invitrogen, Cat No. KNM2040-01). 
 The E. coli cells with the plasmid vector with the desired insert were then plated 
on LB agar plates supplemented with clindamycin for antibiotic resistance (0.5ug/ul) and 
with X-gal for blue-white screening (16µl), and incubated overnight at 37°C. When at 
least one white colony with the desired insert appeared, the colony was swiped with a 
sterile inoculating loop and inoculated with 3mls of LB (Luria-Broth; Affymetrix, 
Cleveland, OH) and allowed to grow overnight in shaking incubator at 37°C. The next 
day, the plasmid DNA vector was isolated from E. coli using the QIAprep Spin MiniPrep 
Kit (Qiagen, Cat. No. 27104). In order to confirm that the plasmid indeed carries the 
desired insert, it was verified via EcoRI digestion for 15 minutes at 37°C (10µl plasmid, 
1ul EcoRI, 3µl 10X Buffer and 16µl distilled water; EcoRI restriction enzyme, NEB, Cat 
No. R0101S). The digested colonies were then run on a gel to confirm size. 
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Figure 6. Schematic diagram of the pCR® 2.1 TA vector with inserted PCR products and 
EcoRI restriction digest sites. 
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2.6 Electroporation and Plating 
From an actively growing blood agar plate with culture, one streak of P. 
gingivalis colonies were swiped with a sterile inoculating loop and inoculated into 3mls 
of BHI media (Bovine Heart Infusion, pH 7.2; Recipe: 37g BHI, 5g yeast extract, 1g 
cysteine HCl, 5ml hemin, 4ml 1M NaOH, 200µl vitamin K). Cultures were grown 
overnight in an anaerobic chamber at 37°C, inoculated in a 1:10 dilution with BHI media 
the next day, and grown overnight in the same conditions again. The following morning, 
1-150 ml bottle of fresh pre-warmed BHI media was inoculated with 500-650µl of 
overnight culture. These cultures were then grown overnight once more in the same 
conditions until the OD660 was between 0.4 and 0.7. Cells were harvested and washed 
twice with electroporation buffer (recipe: distilled water with 10% glycerol, 1mM 
magnesium chloride; filter sterilized). 
 To electroporate and allow homologous recombination (Figure 7), 100µl of cells 
were placed in sterile 0.2cm gap electrode cuvette, 10µg of PCR product were added to 
cells, and cells were pulsed with the BIO-RAD gene pulser set at 2500V (Gene Pulser® 
II Electroporation System; Hercules, CA). In the chamber, 500µl of BHI media were 
added to each cuvette, incubated at 37°C and grown overnight. 
The next day, cells were plated on blood agar plates supplemented with 
clindamycin (0.5µg/ml) and the plates incubated 3-10 days at 37°C until colonies grew. 
Upon colony appearance, colonies were re-streaked on a fresh blood agar plate with 
clindamycin, checked for contamination, and the insert was confirmed via one round of 
PCR followed by gel confirmation. Daily 1:10 culture dilutions were also started for 
quick availability as needed, with OD660 maintained between 0.5 and 1. 
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Figure 7. Electroporation 
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Figure 7. Electroporation is a mechanical transfection method that uses an electrical 
pulse to create temporary pores in cell membranes through which DNA can pass into 
cells. Steps: 1) Electroporation exposes a cell to a high-intensity electric field that 
temporarily destabilizes the membrane; 2) During this time, the membrane is highly 
permeable to exogenous molecules present in the surrounding media; 3) DNA then 
moves into the cell through these holes; 4) When the field is turned off, the pores in the 
membrane reseal, enclosing the DNA inside and 5) allowing homologous recombination 
to occur spontaneously. 
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2.7 Bioinformatics 
 Basic bioinformatics information was generated querying several databases and 
modeling websites for a best-fit homology model of PG0627. Research was also 
conducted to determine if PG0627 is indeed a good candidate gene to code for an RNA-
binding protein in P. gingivalis. First, the Los Alamos National Laboratory P. gingivalis 
database (Los Alamos National Security, LLC, 2010) was used to determine a protein 
database (PDB) structure with high sequence similarity that could be used as a reference 
model for PG0627 protein structure. Next, one-to-one threading by Phyre2 was 
conducted using this reference protein model and PG0627 to generate a homology model 
(Kelley and Sternberg, 2009), and the models and overlays were generated via UCSF’s 
Chimera software. A separate modeling inquiry was also conducted (to confirm validity 
of the generated model) via the Swiss Institute of Bioinformatics (SIB) ExPASy website 
utilizing SWISS-MODEL (Arnold et al., 2006), which is a fully automated protein 
structure homology-modeling server that “models protein tertiary and quaternary 
structure using evolutionary information” (Biasini et al., 2014). As model quality 
estimation is an essential component of protein structure predictions since the accuracy of 
a model determines its usefulness for practical applications, the SWISS-MODEL 
provides model quality estimates based on a QMEAN (quality model energy analysis) 
potential (University of Basel, 2014) specifically re-parameterized for models built by 
SWISS-MODEL (Benkert et al., 2009; Benkert et al., 2011). Further confirmation that 
PG0627 is indeed an RBP was resolved via InterPro (https://www.ebi.ac.uk/interpro/), a 
repository of databases for protein sequence analysis and classification. 
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2.8 Determination of Metal Content 
 From overnight cultures of 6ml grown in BHI, pellets were harvested and washed 
twice with chelex treated buffer (50mM HEPES, 50mM NaCl). This eliminated the 
extracellular metal content present. Next, added to the pellets was 3ml of the same chelex 
treated buffer but supplemented with 8M urea, in order to denature and unfold the DNA. 
Samples were sonicated for three minutes at 20% duty cycle on ice, and centrifuged at 
8500 rpm for 30 minutes. Subsequently, the supernatant was removed from each sample 
for analysis via either ICP-MS or colorimetric ferrozine assay. 
 
2.8.1 ICP-MS 
 Inductively coupled plasma mass spectrometry, or ICP-MS, is an analytical 
technique used for elemental determinations. Using argon gas, elements in the liquid 
samples are converted to ions, and then separated and detected by a mass spectrometer 
(Wolf, March 2005). Results were given as relative abundance of individual metal ions 
(Mg, Fe, Co, Ni, Cu, Zn) in parts per trillion and compared to standards. 
 
2.8.2 Colorimetric Ferrozine Assay 
Fe(II) ions form a magenta colored solution with ferrozine, and this reaction is 
used to quantitatively analyze Fe2+(aq) in solution using a UV-Vis spectrophotometer. 
500µl of sample was incubated with 0.01M ferrozine and 5M ammonium acetate (buffer) 
for five hours anaerobically, and a deep purple color developed. Optical density readings 
were taken at 562nm, the absorbance of the colored reaction, and then relative abundance 
was quantified in parts per million from a standard curve. 
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2.9 Protease Assays 
 N-alpha-Benzoyl-D,L-arginine 4-nitroanilide hydrochloride (DL-BAPNA; Sigma, 
Catalog No. B4875) and D-Phe-Pro-Lys-pNA (Sigma, Catalog No. SCP0126) are 
chromogenic substrates for proteolytic enzymes such as trypsin, amidase, and balterobin. 
Hydrolysis of these substrates at the bond between the arginine and the p-nitroaniline 
moieties (DL-BAPNA) or the lysine and p-nitroaniline moieties (D-Phe-Pro-Lyz-pNA) 
releases the chromophore p-nitroaniline, which can be detected by colorimetric analysis. 
 The remaining 15µl of cells from the transcriptome preparation below was 
resuspended in 200-400µl of PBS, and diluted sufficiently so that when approximately 4-
10µl of sample are combined with 500µl of 1M Tris-HCl pH 8.0 in VIS cuvettes, the 
OD405 reading was near 0.050. 
 
2.9.1 Arg-X Activity 
 For the Arg-X activity assay, 5µl of sample was aliquoted out into a VIS cuvette, 
in triplicates. 500µl of 1M Tris-HCl pH 8.0 with 4mM TCEP were added into each 
cuvette, and a blank was also created. TCEP is a reducing agent used to break disulfide 
bonds. Baseline absorbance values were recorded to ensure all samples were roughly 
around an OD405 of 0.050. 50µl of DL-BAPNA at a concentration of 4.3mg/ml of DMSO 
was quickly added to each cuvette including the blank. After 5 minutes, absorbance 
values were once again taken at 405nm. This was repeated again as needed every 15-30 
minutes until an activity plateau was reached. 
 
2.9.2 Lys-X Activity 
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 For the Lys-X activity assay, 5µl of sample was aliquoted out into a VIS cuvette, 
in triplicates. 500µl of 1M Tris-HCl pH 8.0 with 4mM TCEP was added into each 
cuvette, and a blank was created. Baseline absorbance values were recorded to ensure all 
samples were roughly around an OD405 of 0.050. 25µl of D-Phe-Pro-Lys-pNA at a 
concentration of 4.9mg/ml of DMSO was quickly added to each cuvette, including the 
blank. After 5 minutes, absorbance values were once again taken at 405nm. This was 
repeated again as needed every 15-30 minutes until an activity plateau was reached. 
 
2.10 Total Interactions and Invasions 
 Total interactions and invasions of P. gingivalis strains with eukaryotic human 
umbilical vein endothelial cells (HUVEC) was determined through fluorescent tagging 
with Fluorescein Isothiocyanate (FITC; Sigma, St. Louis, MO), quenching via trypan 
blue and analyzed via flow cytometry (BD FACS Canto II, Becton Dickinson, Franklin 
Lakes, New Jersey). 
 Fresh HUVEC cells were prepared the day before analysis, as well as 3ml of 
bacterial cultures with OD660 readings between 0.4 and 0.7. The bacteria were washed 
twice with PBS anaerobically, resuspended in 1ml PBS and 2µl of FITC was added to 
samples. Samples were mixed for one hour at 4oC in the dark. After incubation, samples 
were returned to the anaerobic chamber, washed twice more with PBS and resuspended 
in 2ml of HUVEC media. Absorbance was once again taken and an MOI of 100 bacterial 
cells to 1 HUVEC (100:1) was made and allowed to incubate for 30 minutes at 37oC 
before reading. 
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 Fluorescence was measured using the BD FACS Canto II flow cytometer 
equipped with an argon ion laser having a single excitation wavelength of 488nm, with 
computer-assisted data analysis. FITC fluorescence was captured (emission wavelength 
of 518nm) and plotted against the number of cells for a calculation of total interaction. 
Total invasion readings were done immediately after interaction readings, by adding 25µl 
of 100ug/ml trypan blue to samples. Trypan blue acted as an extracellular quencher 
thereby only counting invasions. Samples were incubated with trypan blue for no more 
than 2 minutes, as time longer than that will begin to completely rupture the cells. At 
least 10,000 cells were captured and analyzed for each sample for each of the interaction 
and invasion readings. Healthy populations were gated and analyzed using the FCS 
Express software, and gates were set to eliminate any unstained material or debris. 
Median was used as a measurement of relative absorbance of FITC for analysis and 
plotted in a graph. 
 
2.11 Hemin Depletion 
 On day -2, a fresh culture of bacteria in BHI media supplemented with vitamin K 
was grown. The following day, absorbance readings at OD(660) were recorded, and a 
1:10 dilution in BHI media was created and grown until an OD(660) of 1.0. On day 0, a 
1:10 dilution in mycoplasma media supplemented with vitamin K but without hemin was 
made, and OD(660) readings were taken two days later just prior to the next passage. To 
make mycoplasma media, 20 grams of the BBL Mycoplasma Broth Base (BD, St. Louis, 
MO) was suspended in 1 liter of purified water, and mixed thoroughly. The solution was 
then warmed gently until the solution was complete, and autoclaved at 121oC for 15 
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minutes to sterilize. It was finally cooled to 50oC and 200µl of vitamin K enrichment was 
added. 
 Passaging of bacterial samples was done every other day in 1:10 dilutions of 
mycoplasma media without hemin until absorbance readings were less than 0.1. 
 
2.12 Nitrosative Stress 
  Bacterial cultures (10ml) were prepared using mycoplasma media with and 
without 5µg/ml hemin supplemented, and passaged twice before being grown to an 
optical density at 660nm of 0.05 anaerobically. Various concentrations of nitrosative 
stress-generating species were then added to the cultures: nitrate (NaNO3; 40mM, 20mM) 
or nitrite (NaNO2; 8mM, 4mM, and 1mM). 
 Aliquots of 1ml were removed at various time points (0 h, 4 h, 8 h, and 16 h), and 
growth was monitored by measuring the OD(660). Three sets of biological triplicates 
were conducted on different days to ensure significance of the results.  
 
2.13 Oxidative Stress 
BHI-agar plates were prepared (20g/L agar, 37g/L brain-heart infusion, 5µg/ml 
hemin, 5mg/ml yeast extract, 0.5µg/ml vitamin K, 1mg/ml L-cysteine) and allowed to 
equilibrate in the anaerobic chamber. Overnight cultures of W83 and V3139 bacterial 
cells were allowed to grow to a final OD660 of 0.7, and 200µl of 7 x 108 cells/ml cell 
suspension were plated on the BHI-agar plates. After 30 minutes, sterile filter discs were 
placed in the center of each plate, and 90µl of one of the following concentrations of 
H2O2 (used as an oxidizing agent) was added to each filter disc: 1% or 5%. 
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 Plates were wrapped with parafilm and incubated in an anaerobic chamber at 
37oC for 5-7 days or until the diameter of growth inhibition zones created around the 
discs could be measured. 
 
2.14 RNA Sequencing and Library Generation 
2.14.1 Transcriptome  
 From an overnight culture of a mutant strain, a DP positive (2,2-dipyridyl, a high-
affinity iron chelator) and DP negative sample was created. For DP negative samples, 
4.5ml of BHI media was combined with 500ul of bacterial culture. For DP positive 
samples, 20µl of DP, 4.5ml of BHI media, and 500ul of bacterial culture were combined. 
The cultures were then grown anaerobically for 4-6 hours or until the OD660 reached 0.5. 
The cells were harvested, and the pellets resuspended in 50µl of PBS, pH 7.4. Samples 
were frozen at -80oC for long-term storage. 
 
2.14.2 RNA Isolation 
 From the transcriptome preparation above, 35µl wer aliquoted out to use for RNA 
isolation (RNeasy Mini Kit, Qiagen, Catalog No. 74104). Benchtop, pipettors, and tube 
holders were cleaned with 70% ethanol followed by RNase Zap (Life Technologies, 
Catalog No. AM9780) prior to starting. Everything was set up next to an open flame and 
a new box of pipette tips was opened. 500ul of Buffer RLT with beta-merceptoethanol 
was added to the samples, vortexed and transferred to the Lysing Matrix B 2ml tubes 
with 0.1mm silica spheres. To this, 500ul of acid phenol: chloroform was added to 
samples in the fume hood, and samples were bead beated at 6.0 M/S for 45 seconds. They 
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were then immediately placed on ice for 5 minutes, and centrifuged at 4oC for 10 minutes 
at 13000rpm. To fresh microcentrifuge tubes, 400µl of 100% ethanol was added. Then, in 
the fume hood, the supernatant was pipetted out into these new tubes with ethanol added. 
Mixtures were transferred to the RNeasy spin columns, spun down and the flow-through 
was discarded. 600µl of RW1 buffer was then added, spun down and the flow-through 
was discarded once more. 70ul of Buffer RDD was pre-mixed with 10µl of DNase 
enzyme (RNase-Free DNase Set, Qiagen, Catalog No. 79254) per sample. The 80ul 
mixture was added onto each column, and incubated at room temperature for 30-40 
minutes. During this time, a denaturing RNA gel was prepared (below). 
 After incubation, 250µl Buffer RW1 was added to the above spin columns with 
RNA, spun down and the flow-through was discarded. 500µl Buffer RPE was added, 
spun down and the flow-through was discarded again. This last step was repeated once 
more for a total of two times. The nearly empty columns were spun down for 2 additional 
minutes to get rid of any residual wash buffer, and columns were transferred to clean 
microcentrifuge tubes. 50ul of RNase- and DNase-free water was added to the columns, 
incubated for 1 minute, and spun down for 3 minutes at 13000rpm. Concentration of 
RNA were measured using the NanoDrop spectrophotometer, a denaturing RNA gel was 
run for confirmation of RNA isolation, and samples were then stored at -20oC for short-
term or -80oC for long-term storage. 
 
2.14.3 Denaturing RNA Gel 
 Gel apparatus, tray and comb, as well as glassware were all treated with RNase 
Zap and rinsed with nuclease-free water. For the large apparatus, 1gram agarose was 
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melted in 72ml nuclease-free water for about 2 minutes. After cooling, 10ml of 10X 
nuclease-free MOPS buffer was added as well as 1µl Gel Star. In the fume hood, 18ml 
formamide was also added and the gel poured. Combs were then inserted and the gel was 
allowed to solidify in the hood. Samples were prepared using 3µg of sample and 2µl of 
formaldehyde loading dye, bringing samples up to 12-13µl total using nuclease-free 
water. Samples were heated to 55oC for 15 minutes in a water bath. 12µl samples were 
loaded into the gel and 1X nuclease-free MOPS buffer was added. Samples were run at 
35 volts for one hour, and visualized via a UV transilluminator. Intact total RNA run on 
the denaturing gel should exhibit sharp 23S and 16S rRNA bands. 
 
2.14.4 Library Generation 
 RNA isolates were treated with the DNA-free DNase Kit (Life Technologies, 
Catalog No. AM1906) before proceeding. 
 Using NuGEN Technologies Ovation Complete Prokaryotic RNA-Seq DR 
Multiplex Systems Kit (NuGEN Technologies, Catalog Nos. 0326, 0327), cDNA libraries 
were created without the additional step to reduce rRNA levels (Figure 8). This kit is 
designed for strand-specific expression analysis by incorporation of a nucleotide analog 
during the second strand cDNA synthesis and subsequent ligation to a pair of double-
stranded adaptors also containing the same analog in one strand. After ligation, the cDNA 
strand and adaptor containing the analog were selectively removed, leaving only one 
cDNA strand, with both adaptor sequences attached. Unique barcoded adaptors were also 
utilized for up to 16-plex sequencing. Samples were submitted to the Nucleic Acid Center 
for quality check and Illumina Sequencing. 
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Figure 8. cDNA Library Generation Workflow. 
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Figure 8. cDNA Library Generation Workflow. The streamlined workflow consists of a 
double-stranded cDNA generation using selective priming, fragmentation of double-
stranded cDNA, end repair to generate blunt ends, adaptor ligation, strand selection via 
nucleotide analog-targeted degradation and PCR amplification to produce the final 
library. The entire workflow takes approximately 9 hours. Adapted from NuGEN 
Ovation Complete Prokaryotic RNA-Seq DR Multiplex Systems Kit. 
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2.15 Proteomics 
From an overnight culture of a mutant strain, DP positive and DP negative samples 
were created. For DP negative samples, 27.5ml of BHI media was combined with 2.5ml 
of bacterial culture. For DP positive samples, the following was combined in order: 120µl 
of DP with 27.5ml of BHI media and 2.5ml of bacterial culture. Cultures were grown 
overnight in an anaerobic chamber at 37°C. The next day, cultures were grown to an 
OD660 of between 0.5 and 1. Next, the cells were harvested and washed with 100mM 
Tris-HCl, pH8 and resuspended in 1ml of the same buffer. Samples were transferred to 
microcentrifuge tubes and lysed using the ultrasonicator at 50% duty cycle, three times 
for 2 minutes each. Samples were then spun down, and to the cell lysate, 1µl of 
benzonase was added to degrade all DNA and RNA. After 5 minutes of incubation, 1M 
guanidine HCl was added to denature proteins. Samples were then spun down for 10 
minutes at 14000rpm, and the supernatant saved. Acetone precipitation of proteins was 
then done to remove any remaining small soluble substances, and repeated twice. It was 
then resuspended in 100µl of 10mM ammonium bicarbonate, run on a protein gel for 
confirmation, and absorbance at A280nm was taken and noted using the NanoDrop 
Spectrophotometer. Samples were then submitted to the Chemical and Proteomic Mass 
Spectrometry Core Facility (VCU Oliver Hall, 4th Floor) for protein ID with spectral 
counting analysis. This process was repeated for a total of three times, not done 
concurrently to ensure sample integrity. 
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Chapter 3: RESULTS 
 
3.1 Bioinformatics 
Basic bioinformatics was conducted in order to resolve a best-fit homology model 
of the P. gingivalis gene PG0627. Analysis was also done to determine whether PG0627 
is indeed a good candidate for a putative RNA-binding protein. 
 Utilizing Los Alamos Laboratory’s Oralgen server, a protein structure model was 
sought in order to serve as a reference model for homology for PG0627. The top protein 
database hit from PDB was a Homo sapiens gene, N-terminal RRM domain of Cleavage 
stimulation factor 64 KDa subunit (CstF-64), which has a sequence similarity of 62% to 
PG0627 (Figure 9). One chain of this monomer served as a reference model for which 
PG0627 was fitted to using one-to-one threading on Phyre2. The model returned from the 
database had a confidence of 99.79% where 84 of PG0627’s 97 amino acid residues 
perfectly matched to the CstF-64 chain. Models were created using UCSF’s Chimera 
software and the overlay was generated via the MatchMaker structure comparison tool 
(Figure 10). 
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Figure 9. Amino acid sequence alignment of PG0627 and CstF-64. Generated using Phyre2. “Predicted Secondary structure” and 
“Query  Sequence” are for PG0627, while the remaining three lines are for the N-terminal RRM domain of CstF-64. Adapted from: 
http://www.sbg.bio.ic.ac.uk/phyre2/phyre2_output/b1249fb70001e324/summary.htm
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Figure 10. Homology model of putative RNA-binding protein, PG0627. 
A 
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Figure 10. Homology model of putative RNA-binding protein, PG0627, A, in blue. 
Modeled on N-terminal RRM domain of Cleavage stimulation factor 64 KDa subunit in 
H. sapiens, chain A (PDB ID: 1P1T), B, in red. Overlay of the two structures is depicted 
in C with same color scheme. Generated using UCSF’s Chimera software.  
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 To confirm validity of the generated homology model of PG0627, a second 
modeling database inquiry using differing algorithms was done via the Swiss Institute of 
Bioinformatics (SIB) ExPASy website utilizing SWISS-MODEL as well as QMEAN for 
measuring model quality. ExPASy’s SWISS-MODEL tool returned three models, with 
the top hit once again being PDB ID: 1P1T Chain A, the N-terminal RRM domain of 
CstF-64. The total QMEAN score (Table 5), which is a composite score of energetics of 
the model and reflects the predicted global model reliability ranging from 0 to 1, was 
0.814. This indicates the model is a low-energy one and with a significant QMEAN score 
(Benkert et al., 2009; Benkert et al., 2011). The secondary structure agreement was also 
significant at 86.9%. This reaffirmed that the homology model generated both via Phyre2 
and SWISS-MODEL was significant. 
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Table 5. Energetics and QMEAN score of RBP homology model.  
 
Model Name RBP Homology Model 
C-beta interaction energy: -59.56 
All-atom pairwise energy: -3100.55 
Solvation energy: -15.48 
Torsion angle energy: -24.51 
Secondary structure agreement: 86.9% 
Solvent accessibility agreement: 81.0% 
Total QMEAN score: 0.814 
 
* Adapted from: 
http://swissmodel.expasy.org/qmean/cgi/index.cgi?job_id=3bf31efaf8e38667688422fc68
3f3c86 
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 Next, to determine whether PG0627 is indeed a good candidate for a putative 
RNA-binding protein, InterPro was used. InterPro is a repository of databases for protein 
sequence analysis and classification, and can quickly give information about motifs 
within a protein structure (Figure 11). First, the GENE3D database indicated that residues 
4-92 of PG0627 represent a nucleotide-binding domain with an alpha-beta plait structure, 
which is consistent with that of a ferredoxin-like (beta-alpha-beta)2 fold, such as that 
found in RNA-binding domains of various ribonucleoproteins (Bochkarev et al., 1995; 
Kielkopf et al., 2004). Second, three separate databases indicated that the PG0627 protein 
sequence is indeed an RNA recognition motif domain: 1) Pfam, residues 5-74; 2) 
SMART, residues 4-77; and 3) PROSITE, residues 3-81.  
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Figure 11. InterPro database results indicating PG0627 contains a nucleotide-binding 
domain (A) as well as an RNA recognition motif domain (B). Adapted from: 
https://www.ebi.ac.uk/interpro/sequencesearch/iprscan5-S20140618-190020-0897-
20706388-pg   
  
A 
B 
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3.2 Metal Content 
 The graphs in figures 12 and 13 below illustrate the intracellular metal content of 
W83 versus V3139. Overnight cultures were washed with chelex treated buffer and then 
lysed releasing the cells’ intracellular content. Finally, one biological set was analyzed 
via inductively coupled plasma mass spectrometry (ICP-MS) while three biological sets 
of triplicates was analyzed via a colorimetric ferrozine assay.  
 According to figure 12, a decrease in content of the following metals was seen in 
V3139 compared to W83: a 1.57-fold decrease in magnesium, a 1.23-fold decrease in 
iron, a 10.62-fold decrease in cobalt, and a 3.66-fold decrease in nickel. Meanwhile, a 
1.21-fold increase and 2.35-fold increase was seen with copper and zinc, respectively, in 
V3139 compared to W83. 
 According to figure 13, V3139 in iron excess conditions had a1.22-fold decrease 
in intracellular iron compared to W83. In iron-depleted conditions (through the addition 
of 2,2-dipyridyl, or DP), V3139 saw a similar 1.18-fold decrease compared to W83. 
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Figure 12. Intracellular metal content via ICP-MS of W83 and V3139. Values are 
displayed in parts per trillion. Graph shows only one biological set of data. 
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Samples OD(562) Concentration (Parts per million) 
W83 0.1566 2.6136 
V3139 0.1284 2.1443 
W83+DP 0.0982 1.6398 
V3139+DP 0.0831 1.3875 
 
 
Figure 13. Intracellular iron content via ferrozine assay of W83 and V3139. Graph 
depicts three biological sets of triplicates. Optical densities were converted to 
concentrations using an iron standard curve with concentrations of 0.5 ppm, 1.0 ppm, 1.5 
ppm, 2.0 ppm and 2.5 ppm from a 100ppm iron stock solution.  
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3.3 Arg-X and Lys-X Protease Activity 
 The graphs in figures 14 and 15 depict the protease activity of Arg-X and Lys-X 
in V3139 versus W83 strains in both iron-excess and iron-limited conditions. 
 In figure 14, the chromophore p-nitroaniline was released upon the hydrolysis of 
the substrate DL-BAPNA and is reflective of relative arginine protease activity. In iron 
excess conditions, V3139 displays a 1.79-fold decrease in arginine protease activity 
compared to W83. Similarly in iron limited conditions, V3139 shows a 1.59-fold 
decrease in protease activity compared to W83. Overall for both strains, arginine protease 
activity was greater in iron limited conditions than in iron excess conditions. 
In figure 15, the chromophore p-nitroaniline was released upon the hydrolysis of 
the substrate D-Phe-Pro-Lyz-pNA and is reflective of relative lysine protease activity. 
Similar to that seen above, W83 showed a greater lysine protease activity in iron limited 
than in iron excess conditions. However, V3139 saw a significant decrease in lysine 
protease activity in iron limited conditions compared to that in iron excess conditions. 
Additionally, in iron excess conditions, V3139 showed a 1.10-fold decrease in activity 
compared to W83. However, in iron limited conditions, V3139 saw a 2.04-fold decrease 
in lysine protease activity compared to W83. 
Overall for all graphs, the paired student t-test p-values were below 0.05 
indicating that the data is in fact significant and not simply due to chance. 
 Lastly, arginine protease activity is significantly higher than lysine protease 
activity across all strains grown in either iron excess or iron limited conditions. 
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Figure 14. Arginine protease assay. The chromophore pNA is detected at a wavelength 
of 405nm and is thus relative to arginine protease activity when the substrate DL-
BAPNA is used. For ease of viewing, red lines highlight the trends for V3139, while the 
black lines highlight the trends for W83. Three sets of biological replicates were done. 
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Figure 15. Lysine protease assay. The chromophore pNA is detected at a wavelength of 
405nm and is thus relative to lysine protease activity when the substrate D-Phe-Pro-Lyz-
pNA is used. For ease of viewing, red lines highlight the trends for V3139, while the 
black lines highlight the trends for W83. Four sets of biological replicates were done. 
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3.4 Interactions of P.gingivalis Strains with Host 
 The graphs in figure 16 depict the total extracellular interactions and total 
intracellular invasions of V3139 and W83 strains into eukaryotic HUVEC. HUVEC were 
grown to confluency while V3139 and W83 were grown from overnight cultures, 
washed, incubated with FITC and washed again before introduction to HUVEC at an 
MOI of 100:1. Analysis via flow cytometry showed that total extracellular interactions 
had a 1.15-fold decrease between V3139 cells and HUVEC compared to W83 and 
HUVEC. Similarly, total intracellular invasions had a 1.13-fold decrease between V3139 
cells and HUVEC compared to W83 and HUVEC.  
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Figure 16. Total interactions and total invasions of P. gingivalis strains into eukaryotic 
cells. Fluorescent tagging with FITC was used to quantify total extracellular interactions 
between the bacterial strains, either V3139 or W83, and eukaryotic HUVEC. Quenching 
of extracellular FITC by trypan blue was then used to quantify total invasions between 
the bacterial strains and eukaryotic HUVEC. Red asterisk indicates a student paired t-test 
value of p = 0.087; purple asterisk indicates a p = 0.159. Five biological replicates were 
done for each condition. 
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3.5 Growth Studies 
 Two differing growth studies were performed in order to elucidate whether 
V3139 grows differentially compared to W83 in various conditions. 
 
3.5.1 Hemin Depletion 
The graph in figure 17 illustrates growth of V3139 versus W83 strain in hemin-
depleted conditions. A decrease in growth was expected in W83 as hemin, the iron-
containing protoporphyrin, is an essential nutrient for growth of P. gingivalis. However, 
an unexpected occurrence was the high growth of V3139 under conditions of low hemin. 
At day 0, all samples were grown to an OD(660) of 1.0 in BHI supplemented with 
vitamin K. The first 1:10 passage in mycoplasma without hemin was conducted, and an 
OD(660) taken two days later just prior to the second passage. This continued through 
day 8 when the optical density fell below 0.1 for both strains (not pictured). Data from 
day 6, or the third passage, showed statistically useable and valid data and is depicted in 
figure 17. This graph illustrates that V3139 grew better in a hemin-depleted state 
compared to W83, as the OD(660) reading measure at 0.890 for V3139 compared to W83 
which was at 0.673. This translates to a 33% decrease in growth of W83 and an 11% 
decrease in growth in V3139. 
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Figure 17. Growth in a hemin-depleted conditions. Samples were passaged in 
mycoplasma media without hemin added. Data is taken from the third passage of each 
strain. Red asterisk indicates paired student t-test value of p = 0.000325. Number 
displayed above respective bar shows OD(660) value. 
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3.5.2 Nitrosative Stress 
The graphs in figures 18 and 19 illustrate the susceptibility of W83 and V3139 
strains to nitrosative stress. This study utilized various concentrations of nitrosative-stress 
generating compounds added after the first optical density reading, including: NaNO3: 
40mM, 20mM and NaNO2: 8mM, 4mM, and 1mM. Samples were grown in mycoplasma 
buffer supplemented with hemin or without, and OD(660) taken at 0, 4, 8 and 16 hours. 
In both figures 18 and 19, a similar trend is apparent. Under growth with various 
concentrations of nitrate, V3139 grows better than W83 in both hemin-excess and hemin-
limited conditions, with a marked further increase in growth differences in the hemin-
limited conditions. In both strains, there wasn’t a considerable difference in growth 
inhibition between 40mM NaNO3 and 20mM NaNO3. Under growth with various 
concentrations of nitrite, V3139 once again grows better than W83 in both hemin-excess 
and hemin-limited conditions, with a marked further increase in growth differences in the 
hemin-limited conditions. Markedly, V3139 displays a small growth inhibition difference 
between 1mM NaNO2 and 4mM NaNO2, while the wild-type shows a slightly larger 
effect between the two in terms of growth inhibition. Also of note is the decrease in 
overall growth in the hemin-limited condition compared to hemin excess for both W83 
and V3139 strains. 
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Figure 18. Growth study under various sodium nitrate concentrations, with hemin (A) 
and without hemin (B). For ease of viewing, red lines highlight the trends for V3139, 
while the black lines highlight the trends for W83. 
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Figure 19. Growth study under various sodium nitrite concentrations, with hemin (A) 
and without hemin (B). For ease of viewing, red lines highlight the trends for V3139, 
while the black lines highlight the trends for W83. 
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3.6 Oxidative Stress 
The graph in figure 20 illustrates the susceptibility of W83 and V3139 strains to 
oxidative stress. This disc diffusion study utilized cultures grown overnight and plated on 
BHI-agar plates, with two concentrations of hydrogen peroxide added, 1% and 5%. 
Strains were allowed to grow for 5-7 days or until diameters of the zones of growth 
inhibition could be measured for each plate (Figure 21). 
According to figure 20, there is a slight decrease, i.e. 0.03cm, in the diameter of 
the zone of growth inhibition in V3139 strain compared to W83 in 1% H2O2. However, 
for 5% H2O2, there is a marked decrease of 0.16cm in diameter seen with V3139 
compared to W83. The paired student t-test p-value is less than 0.0001 for both studies 
and reflects that although the margins are rather small, the data is significant. 
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Figure 20. Disc diffusion assay with various concentrations of hydrogen peroxide. 
Numbers above bars indicate respective average diameter, in cm, of the zones of 
inhibition for each strain in triplicates. Four biological sets were done. P-value < 0.0001. 
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Samples 1% H2O2 5% H2O2 
W83 4.61 (± 0.02) 6.81 (± 0.02) 
V3139 4.58 (± 0.02) 6.65 (± 0.0001) 
 
Figure 21. Image of the disc diffusion assay for oxidative stress. White-colored 
cloudiness indicates growth zones of respective strain, W83 or V3139. Clear area 
encircling the white filter disks are the measure zones of growth inhibition, diagramed in 
the table as means. Standard deviation are given in parentheses. Four biological sets were 
done. P-value < 0.0001. 
   W83       V3139 
 
 
 
1% H2O2 
 
 
 
 
 
 
 
 
 
5% H2O2 
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3.7 RNA Sequencing 
3.7.1 RNA Isolation 
 From the transcriptome preparation, RNA isolation was conducted on W83 and 
V3139 cells in order to prepare samples for further RNA library preparation. A 
denaturing RNA gel was run to confirm that the RNA did not degrade and could be 
further utilized. The sharp double bands in figure 22 correspond to 23S and 16S rRNA 
and indicate intact RNA samples. Furthermore, there is no apparent streaking also 
confirming good quality samples. 
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Figure 22. Denaturing RNA gel to confirm intact RNA. Gel apparatus, tray and comb, 
and glassware were all treated with RNase Zap and rinsed with nuclease-free water. 1g 
agarose was melted in 72ml nuclease-free water; 10ml of 10X nuclease-free MOPS 
buffer was added, followed by 1µl Gel Star. In the fume hood, 18ml formamide was also 
added. Samples were prepared using 3µg of sample and 2µl of formaldehyde loading 
dye, bringing samples up to 12-13µl total using nuclease-free water. Samples were heated 
to 55oC for 15 minutes in a water bath. 12µl samples were loaded into the gel and 1X 
nuclease-free MOPS buffer was added. Samples were run at 35 volts for one hour, and 
visualized via a UV transilluminator. Lane 1: W83; lane 2: V3139; lane 3: W83 with 2,2-
dipyridyl; lane 4: V3139 with 2,2-dipyridyl. Sharp double bands corresponding to 23S 
and 16S rRNA indicate intact samples. 
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3.7.2 RNA Library Generation 
 RNA isolated from W83 and V3139 was then used to generate RNA libraries as 
described in the materials and methods section. Two biological sets of libraries were 
generated on different dates, and samples were submitted to the VCU Nucleic Acid 
Research Facility in Sanger Hall to be validated and sequenced. 
 
3.7.2.1 Validation of RNA Library 
 The graphs in figures 23-30 depict the bioanalyzer validation results for our 
samples. The results indicate that the RNA libraries I generated were ready for 
sequencing as all samples not only had peaks at less than 1000bp, but also had the largest 
peak at around 800bp indicating good fragment size quality. 
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Figure 23. Electropherogram results from bioanalyzer of cDNA library from W83 RNA 
from 4.24.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
 
 
 
 
Figure 24. Electropherogram results from bioanalyzer of cDNA library from V3139 
RNA from 4.24.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
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Figure 25. Electropherogram results from bioanalyzer of cDNA library from W83+DP 
RNA from 4.24.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
 
 
 
 
 
Figure 26. Electropherogram results from bioanalyzer of cDNA library from V3139+DP 
RNA from 4.24.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
 75 
 
 
Figure 27. Electropherogram results from bioanalyzer of cDNA library from W83 RNA 
from 6.17.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
 
 
 
Figure 28. Electropherogram results from bioanalyzer of cDNA library from V3139 
RNA from 6.17.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
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Figure 29. Electropherogram results from bioanalyzer of cDNA library from W83+DP 
RNA from 6.17.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
 
 
 
Figure 30. Electropherogram results from bioanalyzer of cDNA library from V3139+DP 
RNA from 6.17.14. Y-axis is “FU” of fluorescence units; x-axis is “bp” or base pairs. 
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3.7.3 RNA Sequencing of RNA libraries 
 After cDNA libraries were generated with the NuGEN sequencing kit for both 
W83 and V3139, next-generation sequencing of the whole transcriptome of both was 
performed in order to analyze whether RNA levels change between the two strains.  
 
3.7.4 Statistical Analysis 
 Limited statistical analysis was conducted, as three biological replicates are 
needed for more decisive interpretation. Three separate libraries were generated, 
however, only two has thus far been sequenced with partial results reflected below. Of 
note, “library 1” was not DNase treated while “library 2” was and could account for some 
trend differences. One additional library is currently in the process of being sequenced 
with a fourth library that needs to be prepared. 
Statistical analyses of the transcriptomes were performed by comparing the 
RPKM, or the reads by kilobase transcript per million reads, of V3139 to that of W83 for 
each sequencing data set, library one from 4.24.14 and library two from 6.17.14. From 
these RPKM values, fold changes were calculated to ascertain the differences in RNA 
levels between the two strains, and to view any differences. Both sets included samples 
with 2,2-dipyridyl and samples without it to see if there is differential expression in the 
presence of a high-affinity iron chelator.  
Our target genes of interest are depicted in tables 6 and 7, which list the top 7 up- 
and down-regulated genes in RNA samples of V3139 relative to W83, for the dates of 
4.24.14 and 6.17.14, both with and without 2,2-dipyridyl. Of note, there are two genes 
that occur more than once. PG0627, our putative RNA-binding protein, is the most down-
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regulated gene in our second library of V3139 relative to W83, with a 128-fold and 225-
fold decrease in preparations without and with the iron chelator, respectively. Our first 
library indicated that the gene did not have any copies in the V3139 strain (reflective in 
RPKM values). For comparison, in W83 samples without 2,2-dipyridyl, PG0627 had a 
relative RPKM of 788 reads, while in without 2,2-dipyridyl, PG0627 had a relative 
RPKM of 176 reads. Because fold changes take into account the comparison of two 
values and zero cannot be divided over, no fold changes are displayed for PG0627 for 
this first library and are indicated as “N/A.” Conversely, PG0628, an ABC transporter 
ATP-binding protein, is the most up-regulated gene in RNA samples both with and 
without 2,2,-dipyridyl.  
 Additional target genes of interest are below.  
For RNA samples without 2,2-dipyridyl added, down-regulation of genes in 
V3139 relative to W83 was seen in the following. Three CRISPR-associated proteins, 
PG1985, PG1986, and PG0215 were all down-regulated in the RNA samples without DP. 
These CRISPR-associated proteins have been known to be involved in adaptive 
immunity in bacteria and can serve gene editing purposes. PG0261, an ISPg3 transposase 
was the second most down-regulated gene in V3139 relative to W83, while PG0034, 
coding for a thioredoxin, was the sixth most down-regulated gene. Additionally, PG0539, 
a transmembrane transport protein, was also down-regulated. 
For RNA samples without 2,2-dipyridyl added, up-regulation of genes in V3139 
relative to W83 was seen in the following. PG1480, a conjugative transposon which has 
DNA helicase activity in E. coli was up-regulated in V3139, as was PG1551, which 
codes for the gene hmuY, a heme-binding protein. Additionally, PG1276, a histone-like 
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DNA-binding protein as well as PG0201, a ribonuclease with tRNA binding activity, 
were also up-regulated in V3139 relative to W83. Lastly, PG0900, a cytochrome d 
ubiquinol oxidase subunit, as well as PG0209, a formate/nitrite membrane transporter, 
were also up-regulated in V3139. 
For RNA samples with 2,2-dipyridyl added, down-regulation of genes in V3139 
relative to W83 was seen in the following. Five of the most down-regulated known genes 
in library two exhibited transposase activity, either ISPg3 or ISPg5. Namely, PG2129, 
PG0009, PG0194, PG2058, and PG1645. Additionally, PG2213, a nitrite reductase-
related protein was also down-regulated. In librbary one, however, these transposases 
were mostly up-regulated. However, this was the preparation that was not DNase treated 
and could have skewed the result. Further sequencing data will need to be analyzed to 
conclusively state which trend is more accurate. 
For RNA samples with 2,2-dipyridyl added, up-regulation of genes in V3139 
relative to W83 was seen in the following. PG0223, an exonuclease with nucleic acid 
binding activity, as well as PG0589, a GMP synthase, were the second and third most up-
regulated genes in V3139 relative to W83, respectively. A conjugative transposon protin 
TraF, PG1482, was also up-regulated, as was PG1256, which codes for a ribonuclease. 
Lastly, PG1505, which codes for a radical SAM domain protein and exhibits iron-sulfur 
cluster binding, as well as PG2034, an oxidoreductase, both are also up-regulated. 
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Table 6. Table depicting the top 7 up- and down-regulated known genes from RNA 
samples without 2,2,-dipyridyl, and serve as genes of interest.  
 
Gene ID      
(1) 
Gene Description                                      
(2) 
Cellular 
Location             
(3) 
Function                                                                          
(4) 
Fold change- 
Library 2               
(5) 
Fold change- 
Library 1               
(6) 
PG0627 RNA-binding protein, putative Cytoplasm Nucleotide binding; RRM domain -128.56 N/A 
PG0261 ISPg3 Cytoplasm Insertion sequence element -4.10 -1.21 
PG2015 CRISPR-associated protein Cas4 Cytoplasm CRISPR-associated protein Cas4 -1.99 -7.06 
PG1985 
CRISPR-associated 
protein, TM1792 
family 
Cytoplasm CRISPR-associated Cmr4 family protein -1.82 -1.66 
PG1986 
CRISPR-associated 
protein, TM1793 
family 
Cytoplasm CRISPR-associated Cmr3 family protein -1.76 -4.71 
PG0034 thioredoxin Cytoplasm Electron carrier activity; oxidoreductase activity -1.68 -3.15 
PG0539 
efflux transporter, 
MFP component, 
RND family 
Cytoplasm Transmembrane transport -1.64 -1.32 
 
 
Gene ID      
(1) 
Gene Description                                      
(2) 
Cellular 
Location             
(3) 
Function                                                                          
(4) 
Fold change- 
Library 2               
(5) 
Fold change- 
Library 1               
(6) 
PG0628 ABC transporter, ATP-binding protein Cytoplasm 
Nucleotide binding; ATP binding; transporter 
activity 14.98 10.33 
PG1480 
conjugative 
transposon protein 
TraI 
Unknown 
space 
DNA relaxase, DNA helicase activity (E. 
coli) 7.21 14.44 
PG1551 hmuY protein  Unknown space Heme-binding protein 6.66 -1.18 
PG1276 
DNA-binding 
protein, histone-like 
family 
Unknown 
space Histone-like family DNA-binding protein 7.21 2.83 
PG0201 ribonuclease P protein component 
Unknown 
space Enzyme; tRNA binding; nuclease activity 6.38 1.02 
PG0900 
cytochrome d 
ubiquinol oxidase, 
subunit I 
Cytoplasm Membrane oxidase 5.65 -1.02 
PG0209 formate/nitrite transporter Cytoplasm Formate/nitrite membrane transport 5.31 2.00 
 
* “A” depicts down-regulated genes while “B” depicts up-regulated genes. (1) Gene 
identification in P. gingivalis. (2) Description of the respective gene. (3) Cellular location  
of the respective gene. (4) Cellular function of the respective gene. (5) Fold change of 
library 2 compares the RPKM values of V3139 to that of W83, dated 6.17.14. (6) Fold 
change of library 2 compares the RPKM values of V3139 to that of W83, dated 4.24.14.  
A.
 
 
 
B.
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Table 7. Table depicting the top 7 up- and down-regulated known genes from RNA 
samples with 2,2,-dipyridyl, and serve as genes of interest.  
 
Gene ID      
(1) 
Gene Description                                      
(2) 
Cellular 
Location             
(3) 
Function                                                                          
(4) 
Fold change- 
Library 2               
(5) 
Fold change- 
Library 1               
(6) 
PG0627 RNA-binding protein Cytoplasm Nucleotide binding, RRM domain -225.08 N/A 
PG2129 ISPg5, transposase Orf1 Cytoplasm Insertion sequence element -11.63 5.60 
PG0009 ISPg5 transposase Orf1 Cytoplasm Insertion sequence element -8.31 5.60 
PG0194 ISPg3, transposase Cytoplasm Insertion sequence element -7.87 1.36 
PG2058 ISPg5, transposase Orf1 Cytoplasm Insertion sequence element -5.81 2.24 
PG2213 nitrite reductase-related protein 
Unknown 
space Convert nitrite to NO -5.68 1.00 
PG1645 ISPg5, transposase Orf1 Cytoplasm Insertion sequence element -4.98 N/A 
 
 
Gene ID      
(1) 
Gene Description                                      
(2) 
Cellular 
Location             
(3) 
Function                                                                          
(4) 
Fold change- 
Library 2               
(5) 
Fold change- 
Library 1               
(6) 
PG0628 ABC transporter, ATP-binding protein Cytoplasm 
Nucleotide binding; ATP binding; transporter 
activity 8.64 14.46 
PG0223 exonuclease Cytoplasm Nucleic acid binding; exonuclease activity 4.64 3.73 
PG0589 GMP synthase Cytoplasm ATP --> GMP + AMP 4.18 1.65 
PG1482 
conjugative 
transposon protein 
TraF 
Unknown 
space N/A 3.73 4.48 
PG1256 ribonuclease, Rne/Rng family Cytoplasm RNA binding and processing 3.18 1.28 
PG1505 radical SAM domain protein Cytoplasm Iron-sulfur cluster binding 3.01 1.12 
PG2034 
oxidoreductase, 
FAD-binding, 
putative 
Cytoplasm ferredoxin-NADP(+) reductase subunit alpha 3.00 1.68 
 
* “A” depicts down-regulated genes while “B” depicts up-regulated genes. (1) Gene 
identification in P. gingivalis. (2) Description of the respective gene. (3) Cellular location  
of the respective gene. (4) Cellular function of the respective gene. (5) Fold change of 
library 2 compares the RPKM values of V3139 to that of W83, dated 6.17.14. (6) Fold 
change of library 2 compares the RPKM values of V3139 to that of W83, dated 4.24.14. 
  
A.
 
 
 
B.
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3.8 Proteomics 
 The image in figure 31 is that of a protein gel confirmation after proteomics 
preparation of W83 and V3139 samples. The purpose was to discern whether any 
proteins were up- or down-regulated when comparing W83 to V3139. As is evidenced in 
the gel image, there is no visual shift or change in protein band appearance between the 
two strains. Samples in lanes 2 (W83) and 3 (V3139) were both sent for proteomics 
analysis. Only one set of samples, without an iron chelator, were run and results 
displayed in table 10. However, as the exclusive unique peptide count for both samples 
was relatively low, these results as well as the relative fold changes of protein levels are 
not comprehensive and thus inconclusive. 
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Figure 31. Protein gel. After proteomics preparation, samples were run on a protein gel 
for visual confirmation. Lane 1: protein ladder; lane 2: W83; lane 3: V3139; lane 4: W83 
with 2,2-dipyridyl; lane 5: V3139 with 2,2-dipyridyl. 
 
 
 
 
 
 
 
 
 
 
    1       2         3          4        5 
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Table 8. Proteins and peptides identified via LC-MS. 
 
Protein name (1) 
Protein 
accession 
numbers (2) 
Exclusive unique peptide count (3) 
V3139 W83 Fold-change 
electron transport complex, RnfABCDGE type, C subunit   PG0304 6 1 6.00 
endopeptidase PepO (pepO)   PG0159 4 1 4.00 
ribosomal protein S1 (rpsA)   PG1297 4 1 4.00 
immunoreactive 42 kDa antigen PG33   PG0694 9 3 3.00 
acyl-CoA dehydrogenase, short-chain specific (acdA)   PG1076 9 3 3.00 
ribosomal protein L7-L12 (rplL)   PG0393 6 2 3.00 
delta-1-pyrroline-5-carboxylate dehydrogenase (pruA)   PG1269 6 2 3.00 
acyl carrier protein (acpP)   PG1765 3 1 3.00 
succinate-semialdehyde dehydrogenase (sucD)   PG0687 11 4 2.75 
superoxide dismutase, Fe-Mn (sodB)   PG1545 11 4 2.75 
glutamate dehydrogenase, NAD-specific (gdh)   PG1232 32 12 2.67 
peptidase, M24 family   PG1210 8 3 2.67 
NAD-dependent 4-hydroxybutyrate dehydrogenase (4hbD)   PG0689 5 2 2.50 
MotA-TolQ-ExbB proton channel family protein   PG0782 12 5 2.40 
4-hydroxybutyryl-CoA dehydratase (abfD)   PG0692 33 14 2.36 
immunoreactive 43 kDa antigen PG32   PG0695 7 3 2.33 
phosphoenolpyruvate carboxykinase (ATP) (pckA)   PG1676 7 3 2.33 
lipoprotein RagB (ragB)   PG0186 31 14 2.21 
branched-chain amino acid aminotransferase (ilvE)   PG1290 13 6 2.17 
ferritin (ftn)   PG1286 10 5 2.00 
aminoacyl-histidine dipeptidase (pepD-2)   PG0537 6 3 2.00 
thioredoxin reductase (trxB)   PG1134 4 2 2.00 
hypothetical protein   PG1341 4 2 2.00 
peptidase, M16 family   PG0196 2 1 2.00 
internalin-related protein   PG0350 2 1 2.00 
NAD(P)H dehydrogenase, quinone family, putative   PG1816 2 1 2.00 
urocanate hydratase (hutU)   PG1872 2 1 2.00 
lipoprotein PG3   PG2054 2 1 2.00 
phosphoserine aminotransferase (serC)   PG1278 15 8 1.88 
peptidylarginine deiminase   PG1424 12 7 1.71 
ragA protein (ragA)   PG0185 39 23 1.70 
triosephosphate isomerase (tpiA)   PG0623 5 3 1.67 
peptidyl-dipeptidase Dcp (dcp-1)   PG0758 5 3 1.67 
alkaline phosphatase, putative   PG0890 5 3 1.67 
immunoreactive 53 kDa antigen PG123   PG2167 9 6 1.50 
lipoprotein, putative   PG0611 3 2 1.50 
Dps family protein   PG0090 7 5 1.40 
heme-binding protein FetB (fetB)   PG0669 11 8 1.38 
thioredoxin (trx)   PG0034 4 3 1.33 
hemagglutinin protein HagE (hagE)   PG2024 8 7 1.14 
rubrerythrin   PG0195 2 2 1.00 
hemagglutinin protein HagA   PG1837 2 2 1.00 
arginine-specific cysteine proteinase (prtRII)   PG0506 1 1 1.00 
hypothetical protein   PG0706 1 1 1.00 
extracellular protease, putative   PG0553 4 5 -1.25 
purine nucleoside phosphorylase I, inosine and guanosine-
specific   PG0558 1 2 -2.00 
 
* (1) Name of P. gingivalis protein identified. (2) Respective gene identification number. 
(3) Exclusive unique peptide count is reflective of the number of peptides spectrally 
counted per sample. The LC-MS system consisted of a Thermo Electron LTQ-Orbitrap 
hybrid mass spectrometer system with a nanospray ion source interfaced to a Waters 
NanoAcquity C18 reversed-phase capillary column.  The data were analyzed by database 
searching using the Sequest search algorithm against P. gingivalis database.   
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3.9 Hypothetical Model of the Role of P. gingivalis RBP 
 Based on the role of RBPs across various species as well as analyses conducted 
for this thesis, a hypothetical model of the role of RBP in P. gingivalis was created, and 
could potentially act in three ways as depicted in figure 32. First, RBP could complex 
with a small RNA to repress translation. Alternatively, the RBP-sRNA complex could 
assist in enhancing translation. Finally, RBP could itself cleave the target mRNA.  
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Figure 32. Hypothetical model of the role of P. gingivalis RBP. First, RBP in association 
with a small RNA (sRNA) may sequester the ribosomal binding site (RBS) of a target 
mRNA, thus blocking binding of the 30S and 50S ribosomal subunits and repressing 
translation. Second, a complex of RBP with a sRNA may prevent the formation of a 
secondary structure on the 5’ untranslated region of the target mRNA, and thus enhance 
translation. Lastly, RBP may induce cleavage of the mRNA thereby degrading it. RBP is 
shown in red, the RBS in orange, the sRNA in yellow, the 30S ribosomal subunit in green 
and the target mRNA in dark blue. 
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3.10 Generation of Δ0893, Δ1421, Δ1820, and Δ1821 PCR Products 
 The Δ0893 mutant strain contains a knockout deletion of the PG0893 gene as well 
as a 1.1kb insert of the ermF cassette marker, an antibiotic resistance gene cassette 
marker for erythromycin and clindamycin (Fletcher and Macrina, 1991).  Likewise, 
Δ1421, Δ1820, and Δ1821 all also contain a knockout deletion of their respective gene 
with an insert of the ermF cassette. Repeated cycles of targeted polymerase chain 
reaction (PCR) amplification of genomic P. gingivalis were conducted for each gene in 
order to acquire the desired knockout product. For each gene, three separate PCR reaction 
setups were conducted in order to amplify each flanking DNA fragment, and samples 
were run on a 1% agarose gel to confirm fragment length (Figure 33). Mut1 Δ0893 
amplification shows a length of 337bp and Mut2 Δ0893 amplification has a length of 
328bp. Likewise, the amplification lengths of the remaining three genes was as follows: 
Δ1421 (Mut1: 335bp; Mut2: 323bp), Δ1820 (Mut1: 349bp; Mut2: 300bp), and Δ1821 
(Mut1: 300bp; Mut2: 337bp). Plasmid V2198, containing the ermF, was used as a 
template to amplify the ermF clindamycin resistance cassette, and when run on a 1% 
agarose gel, had a length of 1.1kb.  
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Figure 33. Agarose gel of initial PCR products, “Mut1” and Mut2” for respective genes. 
Gel was made by combining 50ml of TAE buffer (National Diagnostics, catalog No. EC-
872) with 0.5mg of agarose, and heating. 2µl of GelRed Nucleic Acid Gel Stain dye 
(Biotium, catalog No. 41003) was added and mixed before pouring and solidifying the 
gel. Samples were combined with loading dye for visualization and image was taken via 
UV transilluminator. Lane 1, 1kb ladder; lane 2: Mut1 of PG1820; lane 3: Mut2 of 
PG1820; lane 4: Mut1 of PG1821; lane 5: Mut2 of PG1821; lanes 6 & 7: ermF. Bands 1-
5 are between 300-349bp in size. Mut1 corresponds to upstream gene amplification while 
Mut2 corresponds to downstream gene amplification. The ermF cassette, 1.1kb, is shown 
in lanes 6 and 7. 
  
   1        2    3   4        5      6        7        
~300-349bp 
~1.1kb 
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 Next, the flanking regions from this initial PCR were annealed together through a 
fusion PCR protocol using Mut1 Δ0893, ermF and Mut2 Δ0893 as templates (Figure 34). 
The same was done with the remaining three genes. The purified DNA construct was run 
on a 1% agarose gel and had a resulting length of 1690bb for Δ0893, 1683bb for Δ1421, 
1674bb for Δ1820, and 1662bp for Δ1821 (Figure 35). These sizes indicated that the 
individual initial fragments, Mut1, ermF, and Mut2, annealed together and in the correct 
order in the fusion PCR. 
  
  
 90 
 
 
 
 
TTATGCGATCAGCGTCCGAATATCTTCTTCGACCGTACCGATACCTGCTATACCGAAGTTTTCGATCAGC 
ACTTTCGCTACATTCGGTGATAGGAATGCAGGTAGGGTAGGGCCTACATGGATGTTCTTGACACCGAGGC 
TGAGTAGAGCGAGCAGGACGATGACAGCTTTCTGTTCGTACCATGCAATGTTGTAGACGATCGGTAGTTT 
GTTGATGTCATCCAATCCCATTACTTCTTTCAGCTTCAGGGCAATTACCGCCAGCGAATAACTGTCATTA 
CACTGTCCGGCATCGAGAACGCGAGGGATGCCCCCAATGTCGCCAAGCTGCAATTTGTTGTATCGGAACT 
TGGCGCATCCCGATGTAAGGATAACCGTATCGGAAGGAAGAGCTTCGGCAAACTCCGTGTAATAATTGCG 
CCCACTCTGCCGGCCGTCACAACCGCTCATCACTACAAACTTGCGGATCGCTCCACTGCTGACAGCCTCC 
ACTACTTTGTCGGCGATGCTCAATACCTGATGGTGTGCAAAGCCTCCTATGATAGTGCCGCTCTCAATCT 
CTGTGGGAGGTTGGCACGTCTTGGCCAAGGCAATGATTTCGCTGAAGTCCTTGCGCCCGTGCTGATCGCT 
CTCGATGTACTTGAATCCCGGATAGCCCGTAGCGTTGGTGGTAAATACCCGATCCTTGTAGGAAGCATTG 
GCCTTAGGGGGGACGATACAGTTTGTGGTGAAAAGGATAGGGCCGTTGAAGGTTTCGAACTCCTCACGCT 
GTTTCCACCATGCATTGCCGTAATTGCCGAAGAAGTGGTTGTATTTTTTGAATTTGGGATAATAGTTGGC 
CGGTAGCATTTCACCGTGTGTGTACACATCTATTCCTGTTCCTTCAGTTTGCTCGAGCAGCATCTCCATA 
TCTTTCAGATCATGACCGCTGATAAGGATACCCGGGCGCGAACCGACACCTATATTTACTTCCGTGATTT 
CCGGATTGCCATAAGTCTCGGTATTAGCTTTGTCGAGCAGAGCCATTACCTTCACTCCGAAAGAACCGGT 
TTCCAGTACAAGAGCCGTCAGCTCTTCTGCCGAAAGCAATCCCATCGTCACATCGTGCAGCGCACGTTCG 
GTGAAGGCATTGATCTCTTCATCCACGTAGCCGAGTCGATCCGCATGCTCCGCATAGGCTGCCAATCCTT 
TGAGTCCATAGATCGTCAGCTCTTTGAGAGAACGTACATCTTCGTCTGTCTCTCTTAGAATACCTACACT 
GAGAGCCAACCGATCATATTCTTCCGGCTTTCCCTGCATCGTCACTGCTTCATTTTCGGGAAGCTCTATG 
CCTTGAGTAAAAGCCAAACTGTACAATTCCGCTTTGAGTGCGAACGTTTTCTCTACACGTTTGGCTATGG 
AAGAGTAGTCGAAGTTGGCATTGGTAATTGTGGCAAATAGAGATTCCATGATCGCCTTGTCAGCCTTTCG 
GTAATCGGCTTTCACTCCGGCACGCCTCATAGAAGTCATTATGATGGCAATACCTTTGAGGTTAAAGACG 
AGCAAATCCATCAGATTAGCTGTACTAAAGTCCTTACCGCATACCCCTTTGAGGATACATCCCTTATTGC 
CGGCTGTTTCCTGGCATTGATAGCAAAACATTTTCTTTTCCAT 
 
 
 
Figure 34. Disruption of the PG0893 gene via insertion of the ermF cassette between the 
upstream (red) and downstream (blue) PCR amplification products. The full gene is 
depicted in black. Two sets of primers were created for each up- and downstream region 
in order to introduce ermF in between the two. Black arrows indicate the two sets of 
primers for upstream and downstream regions. 
  
 
Upstream 
 
 
 
 
 
 
         ErmF  
          insertion 
 
 
 
 
 
 
 
 
 
Downstream 
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Figure 35. Agarose gel confirmation of PCR fusion products with ermF cassette inserted. 
Gel was made by combining 50ml of TAE buffer with 0.5mg of agarose, and heating. 2µl 
of GelRed Nucleic Acid Gel Stain dye was added and mixed before pouring and 
solidifying the gel. Samples were combined with loading dye for visualization and image 
was taken via UV transilluminator. Lane 1: 1kb ladder; lane 2: Δ1421; lane 3: PG1421 
gDNA (control); lane 4: Δ1820: lane 5: Δ1821; lanes 6: Δ0893. Band size at around 
1.7kb indicates a correctly fused product with Mut1, ermF, and Mut2 of each respective 
gene. 
  
    1         2        3         4         5        6  
 
~1.7kb 
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The desired fused PCR fragments were all cloned separately into the pCR 2.1 TA 
cloning vector that carries both an ampicillin (bases 2129-2989) and kanamycin (bases 
1317-2111) antibiotic resistance-encoding gene. The desired PCR fusion product was 
inserted between the M13 forward primer (bases 389-404) and the reverse primer (bases 
205-211). This 3.9kb vector also contains the lacZ gene for blue-white screening if 
needed. The candidate pCR 2.1 vector with the desired ligated PCR fusion product was 
then transformed into TOP10 E. coli chemically competent cells to check for gene 
insertion. This was done with each of the four knockout genes. After transformation, the 
mixture was spread on LB plates supplemented with X-gal and kanamycin to grow 
overnight. Transformed E. coli containing the plasmid with kanamycin resistance gene 
were able to grow on the LB plate, and both blue and white colonies appeared. Only 
white colonies were candidates for successful ligations. E. coli containing a functional β-
galactosidase enzyme (encoded by the lacZ gene) metabolized the galactose sugar (X-
gal) on the LB plate, forming a blue pigmented colony. E. coli containing the vector with 
the desired PCR fused product inserted within the lacZ gene would disrupt the β-
galactosidase enzyme activity, turning the colonies white. 
 Plasmids were isolated from numerous white colonies for each gene knockout and 
digested with the EcoRI restriction enzyme. EcoRI restriction enzyme sites were located 
on both sides of the PCR fused product insertion and resulted in two DNA fragments at 
6kb (vector with insert) and roughly 1680bp for each of Δ0893, Δ1421, Δ1820, and 
Δ1821, if insertion is correct. Digestions of all candidates for all four genes were run on 
1% agarose gels for confirmation (Figure 36, only Δ1820 and Δ8093 shown). Plasmid 
digestion of colony in lane 2 shows one fragment of approximately 6kb in size and one 
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band less than 250bp. The colony in lane 5 shows a sole 6kb band, while the colony in 
lane 7 shows one band at 6kb and one band at 650bp. The colony in lane 11 shows one 
band at 6kb and one at 1.2kb. All four of these colonies show that the vector with insert 
was not successfully digested by the EcoRI restriction enzyme as no band at 1680bp is 
observable. One possible reason this could be the case is that not enough EcoRI was 
added to the sample. Colonies in lanes 3, 4, 6, 8, and 9 all contain one band at 6kb and 
one at approximately 1.7kb, indicating that the construct (PG1820 in this case) was not 
only ligated correctly into the plasmid, but also that enough restriction enzyme was used 
to digest out the construct. Likewise, colonies in lanes 10 and 12 contain one band at 6kb 
and one at approximately 1.7kb, indicating that the construct (PG0893 in this case) was 
ligated correctly into the plasmid like above. These 7 candidate plasmids were then 
transformed into chemically competent E. coli cells and stored at -80oC for future use. 
 Meanwhile, the fused PCR products of these and additional colonies were used 
and amplified in large volumes for electroporation into P. gingivalis electrocompetent 
cells to obtain mutants of Δ0893, Δ1421, Δ1820, and Δ1821. Fresh purified PCR products 
were used for electroporation as opposed to the plasmids in order to preserve the 
plasmids after months of electroporation. No successful mutant candidates were 
elucidated. 
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Figure 36. Gel confirmation of EcoRI digestion of plasmid DNA of Δ1820 and Δ0893. 
Gel was made by combining 100ml of TAE buffer with 1mg of agarose, and heating. 4µl 
of GelRed Nucleic Acid Gel Stain dye was added and mixed before pouring and 
solidifying the gel. Samples were combined with loading dye for visualization and image 
was taken via UV transilluminator. Lane 1: 1kb ladder; lanes 2-9: Δ1820; lanes 10-12: 
Δ0893. Lanes 3, 4, 6, 8 and 9 of Δ1820, as well as lanes 10 and 12 of Δ0893 all represent 
isolated pCR 2.1 vector + insert of interest. Lanes 2, 5, and 7 of Δ1820, as well as lane 11 
of Δ0893 show either no vector+insert or else the incorrect band size. (Some positive 
bands at 1.7kb are very faint in image but existent.)  
 
 
 
  A     B      C      D      E      F      G     H      I       J       K ~1.7kb 
~6kb 
    1     2      3     4     5     6      7     8     9     10     11    12    
~250bp 
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Chapter 4: DISCUSSION 
 
In all organisms, RNA-binding proteins, or RBPs, play an important role in 
regulating gene expression by modulating RNA transcription, translation, processing and 
stability (Hajnsdorf and Boni, 2012)In bacteria, RBPs may be highly specific for one to a 
few RNA targets, or function as global regulators implicated in numerous regulatory 
networks without strict sequence specificity. Despite their evolutionary significance, 
there has yet to be an RBP resolved in the oral bacterium P. gingivalis, which is a major 
etiological agent in the initiation as well as progression of periodontal disease (Ray et al., 
2013). In order to determine whether P. gingivalis in fact contains an RBP, the gene 
PG0627 was hypothesized to be a putative RBP and was thus characterized functionally 
to determine its biological role in response to several environmental cues. 
 Using bioinformatics and sequence homology across various species, our lab 
identified gene PG0627 as a putative RBP, and thus was further investigated. BLAST 
results showed that the nucleotide sequence of this gene had sequence similarities with 
three other organisms: 1) residues 1-76 of Treponema pallidum had 54% similarity, 2) 
residues 3-76 of Synechocystis sp. 53% similarity, and 3) residues 1-76 of Brugia malayi 
had 50% similarity (Table 1). Furthermore, the protein sequence of the N-terminal RRM 
domain of Cleavage stimulation factor 64KDa subunit (PDB:1P1T) had a 62% similarity 
to that of PG0627 (Table 2). From this information, a homology model for the RBP was 
generated using one-to-one threading by Phyre2. After using UCSF’s Chimera software 
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to model the two monomers and alignment was done via MatchMaker, the overlay 
showed how well fit PG0627 was to the N-terminal RRM domain of CstF-64 (Figure 10). 
For confirmation, a second modeling database inquiry using SWISS-MODEL was done, 
and a QMEAN composite score measuring the model’s quality was generated. The 
QMEAN was 0.814, indicating the model was of low energy as desired. The secondary 
structure agreement between the two models was also significant at 86.9% (Table 5).  
 As the N-terminal RRM of CsfF-64 in H. sapiens was the closest protein 
sequence hit to PG0627, research was done to deduce if function, in addition to structure, 
was also in parallel. CstF-64 binds a wide range of G/U-rich sequences on single-
stranded RNA with comparable affinity, yet is not highly specific for any one target 
sequence (Canadillas and Varani, 2003). Thus, much like that of RBP, it displays slow 
kinetics and has the ability to bind tightly to a class of sequences without strong 
preference for any particular sequence, yet it can discriminate effectively against other 
RNAs. RBPs are known to bind to various motifs and ribosomal binding sites in order to 
instill their effect in degrading or stabilizing RNA, as well as inhibiting translation among 
other effects (Vogel and Luisi, 2011). 
To further determine whether PG0627 was indeed a good candidate for a putative 
RBP, protein analysis of motifs was done via InterPro. Through GENE3D, it was 
determined that residues 4-92 of PG0627 represent a nucleotide-binding domain with an 
alpha-beta plait structures, such as that found in RBDs of various ribonucleoproteins. 
Pfam, SMART, and PROSITE databases also indicated that the PG0627 protein sequence 
indeed had an RNA recognition motif domain. These bioinformatics data gave us strong 
confidence that PG0627 could indeed be a good candidate for RBP, and led us to further 
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investigate its biological role in P. gingivalis. A previously-generated P. gingivalis W83 
mutant deficient in the PG0627 gene was used in all ensuing studies. 
 In order to test our hypothesis, our first aim was to determine the intracellular 
content of various metals in V3139 compared to W83. Of particular interest was that of 
iron levels given its essential role as a nutrient in P. gingivalis. Comparative studies 
between W83 and V3139 strains were conducted and graphed in figures 12 and 13. The 
first is analysis via ICP-MS, and the second via a colorimetric ferrozine assay adapted for 
anaerobic conditions in order to minimize oxidation of iron. ICP-MS results only contain 
one biological replicate as the machinery went down for an extended amount of time, so 
the results are only preliminary. Given that we do not know the biological role yet of 
PG0627 and that is what is being investigated, we had no expected results regarding 
intracellular metal content differences between the wild-type and V3139, or even if there 
would be any. From figure 12, it is evident that V3139 shows a decrease in levels of 
magnesium, iron, cobalt, and nickel, and an increase in levels of copper and zinc. Of note 
is that the fold-change of intracellular iron between the wild-type and V3139 is a 1.23-
fold decrease, indicating that the mutant is somehow a less efficient transporter of iron 
than W83.  
Given the limited scope of a single biological replicate analyzed via ICP-MS, we 
decided to perform a colorimetric ferrozine assay adapted for anaerobic conditions to 
further analyze the intracellular iron content of our samples. Samples were prepared both 
with and without 2,2-dipyridyl, a high-affinity iron chelator. Its purpose is to limit 
available extracellular iron for transport into the cell, and thus mimics iron-limited 
conditions. From figure 13, it is evident that in iron-excess conditions, a 1.23-fold 
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decrease in intracellular Fe(II) was seen in V3139 compared to W83. Similarly, in iron-
limited conditions, a 1.18-fold decrease was seen in V3139. Taken together, these results 
indicate that V3139 is a less efficient transporter of iron than the wild-type regardless of 
the iron availability. This is also consistent with the ICP-MS results above in fold-
change, despite the ferrozine assay protocol not being fully optimized. Sample 
preparation was not indicated on the ferrozine assay protocol, so we prepared samples in 
the same manner as for the ICP-MS protocol. Furthermore, while the ferrozine assay 
protocol indicated that an evident color change would occur in 10 minutes, our 
experience was that it took five hours to see a full color change. For this reason, a more 
optimized ferrozine assay protocol may need to be generated and samples repeated. 
Alternatively, a radioactive hemin uptake assay may instead be conducted to further 
confirm intracellular iron levels, and it would serve as a better indicator of iron transport 
and related machinery. 
Our next aim was to determine the protease activity on the extracellular surface of 
V3139 and the wild-type, and whether they differed. Three to four biological replicates of 
arginine-specific and lysine-specific assays were done in conditions with and without an 
iron chelator. Based on V3139 (above) exhibiting lower levels of intracellular iron 
content than W83, it can be expected that a difference in protease activity can also be 
seen as these gingipains are involved in hemin acquisition. From figure 14, a few 
inferences can be made about arginine-specific protease activity. First, in iron-excess 
conditions, V3139 displays a 1.79-fold decrease in arginine-specific protease activity 
compared to W83. Similarly, in iron-limited conditions, V3139 shows a 1.59-fold 
decrease in activity compared to the wild-type. Overall for both strains though, arginine-
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protease activity was greater in iron-limited than in iron-excess conditions. Though this 
last observation is less common with P. gingivalis, it is not altogether surprising. A ChIP-
seq study by Scott et al. showed that in the absence of hemin, there were more copies of 
the promoter for rgpA, the gene coding for the Arg-X protease (Scott et al., 2013). 
Lysine-specific protease activity was also analyzed and graphed in figure 15. First, in 
iron-excess conditions, V3139 exhibits only a slight decrease in activity, i.e. 1.10-fold, to 
that of W83. However, in iron-limited conditions, results are markedly different. In this 
environment, while the wild-type shows a similar fold-change increase to that of wild-
type in iron-excess conditions, V3139 has a considerable decrease in lysine protease 
activity in the iron-limited versus the iron-excess state. Namely, V3139 had a 2.04-fold 
decrease in lysine protease activity compared to the wild-type in iron-limited conditions, 
and a 1.59-fold decrease to that of V3139 in iron-excess conditions. The same ChIP-seq 
study referenced above also saw that, in iron-limited conditions, there were more copies 
of the promoter for kgp, the gene coding for the Lys-X protease (Scott et al., 2013)While 
this can explain the activity of W83 increasing in iron-limited conditions, it doesn’t 
support the same conclusion for V3139. With that, it’s possible that the absence of iron in 
fact down-regulates kgp in the V3139 strain, but further sequencing studies would need to 
be performed. 
Our next aim was to determine the virulence ability between our W83 and V3139 
by performing total interactions and total invasion assays utilizing HUVEC eukaryotic 
cells. Both strains were labeled with the fluorophore FITC before incubation with 
eukaryotic HUVEC. FITC was used to determine extracellular interactions between each 
of our two strains and HUVEC, while trypan blue was later added to quench those 
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extracellular interactions and only allow for fluorescent measurement of invading 
bacteria. Our results as depicted in figure 16 show that V3139 was somewhat decreased 
in its virulence ability as compared to the wild-type. Specifically, there was a 1.15-fold 
decrease of total extracellular interactions with V3139 than with the wild-type. Similarly, 
a 1.13-fold decrease in total invasion of HUVEC with V3139 compared to the wild-type 
was seen. Taken together, these fold-changes are not vastly different, but could indicate 
differing levels of RNA or proteins specifically involved in virulence in V3139 compared 
to the wild-type. An early study by Van Steenbergen et al. showed that protease 
deficiency in P. gingivalis was correlated with lower virulence (Van Steenbergen et al., 
1987)Given that V3139 exhibited a lower protease activity than our wild-type, that could 
be a potential reason why virulence was also decreased in V3139. Of note, paired student 
t-test p-values were rather high, 0.087 for total interactions and 0.159 for total invasions 
meaning that replication of the results was difficult, and that chance accounted for nearly 
9% and 16%, respectively. This could be due to flow cytometry methods used or because 
the fluorophore used, FITC, may not be the optimal choice. Eight biological replicates 
were performed before five of these were consistent enough in their trends for use. 
However, interaction and invasion studies done on plates may give further information 
and should be attempted in the future. 
 Our next aim was to determine if growth changes were evident between V3139 
and the wild-type in the limitation of available hemin. A decrease in growth was expected 
in the wild-type as hemin, the iron-containing protoporphyrin, is an essential nutrient for 
growth in P. gingivalis. A similar trend would be expected for V3139 unless it was 
somehow involved in iron transport. From figure 17, it is evident that V3139 grew 
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considerably better in the hemin-limited condition compared to the wild-type. This 
translated to a 33% decrease in growth of the wild-type versus an 11% decrease in 
growth of V3139. This suggests that the mutant is somehow more efficient in iron 
transport and scavenging for any available iron. Published data by Genco suggests that as 
the availability of hemin is decreased, the expression of virulence factors is decreased, 
and this in turn results in decreased virulence potential (Genco, 1995). However, given 
our previous results above that both protease activity and virulence are decreased in 
V3139 compared to the wild-type, there must be another explanation why, under hemin 
limitation, V3139 grows better than the wild-type. One possible reason as explained 
below in the sequencing results, is the up-regulation of PG0628, an ABC transporter 
whose function it is to carry heme across the periplasm and inner membrane (Nikaido and 
Hall, 1998). So, when hemin is limited, V3139 employs an alternative strategy to 
transport hemin intracellularly. An alternative method that could be done in the future to 
confirm the role of PG0627 in iron transport and/or related machinery is through a 
radioactive hemin uptake assay. 
 Our next aim was to determine if growth changes were evident between V3139 
and the wild-type in the presence of various concentrations of nitrosative stress 
compounds. As P. gingivalis has a nitrosative stress protection network, it is important to 
ascertain whether PG0627 may play a role. If it does, we would expect to see less growth 
inhibition in V3139 than the wild-type when either nitrate and/or nitrite are added in 
various concentrations. Figures 18 and 19 outline our results and hint at the possibility 
that PG0627 may play role in the nitrosative stress protection mechanism, though it is 
somewhat inconclusive. Under growth with various concentrations of nitrate, V3139 
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grows better than W83 in both hemin-excess and hemin-limited conditions, with a 
marked further increase in growth differences in the hemin-limited conditions. In both 
strains, there wasn’t a considerable difference in growth inhibition between 40mM 
NaNO3 and 20mM NaNO3. Under growth with various concentrations of nitrite, V3139 
once again grows better than W83 in both hemin-excess and hemin-limited conditions, 
with a marked further increase in growth differences in the hemin-limited conditions. 
Markedly, V3139 has a small growth inhibition difference between 1mM NaNO2 and 
4mM NaNO2, while the wild-type sees a slightly larger effect between the two in terms of 
growth inhibition. Also of note is the decrease in overall growth in the hemin-limited 
condition compared to hemin excess for both W83 and V3139 strains. Taken together, it 
can be said that PG0627 may potentially play a role in the nitrosative stress protection 
mechanism, but further sequencing and/or proteomics results may garner further 
information. Furthermore, the growth inhibition seen in the hemin depletion assay 
(above) was re-confirmed here with the controls, i.e. V3139 grew considerably better in 
hemin-limited conditions than W83. Of note, is that this nitrosative stress protocol was 
repeated several times with varying results. The first three replicates exhibited similar 
trends as expressed here, i.e. V3139 grew better than the wild-type in both hemin-excess 
and hemin-limited conditions, and in the presence of either nitrate or nitrite. The second 
set of triplicates showed the exact opposite data, i.e. W83 grew better than V3139 across 
all conditions and in the presence of all nitrosative stress-inducing compounds. This third 
set re-confirmed what the initial triplicate set of data exhibited so was utilized here. 
Our next aim was to determine if V3139 grows differentially in response to 
oxidative stress when compared to W83. P. gingivalis also has a complex oxidative stress 
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protection network in which is combats reactive oxide species (ROS) and the particularly 
lethal hydroxyl radical. As nitrosative and oxidative stress have some overlap in their 
conversion products, it is significant to ascertain whether PG0627 also plays a role in 
protecting the bacterium in the presence of these harmful oxidative species. From figures 
20 and 21, it is possible that PG0627 may play a small role in the oxidative stress 
protection mechanism, though the margins are rather small. The zone of inhibition of 
V3139 was just slightly bigger in the presence of both 1% and 5% H2O2 than for W83. 
This could be significant, though further testing would need to be done, including 
potentially a spectrophotometric growth assay similar to that conducted in the nitrosative 
stress approach. 
As RBPs work co- or post-transcriptionally, our next aim was to determine 
whether there are differential RNA levels between V3139 and W83. Three libraries were 
generated, though only two have thus far been sequenced and are covered in this thesis. A 
third replicate is currently in the process of being sequenced. Given this, the data 
presented here is only preliminary and more replicates must be conducted for 
confirmation of results.  
In iron-excess conditions (Table 6), when the RBP gene is missing, three 
CRISPR-associated proteins are down-regulated, PG1985, PG1986, and PG0215. These 
are involved in adaptive immunity and could be down-regulated if they are dependent on 
a functional RBP. Additionally, an ISPg3 transposase is also down-regulated, and could 
indicate potentially play role in quickly regulating other genes or proteins. Conversely, 
hmuY, a heme-binding protein (PG1551) as well as PG0628, an ABC transporter 
involved in transporting heme across the periplasm and inner membrane, have both been 
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up-regulated. This, along with the increase in growth of V3139 under hemin-depleted 
conditions, could indicate that V3139 is indeed involved in hemin transport. DNA 
machinery (PG PG1276) as well as translational machinery (PG0201) have also been up-
regulated hinting that RBP may be involved in enhancing translation potentially. 
Likewise, the up-regulation of PG0209, a formate/nitrite transporter, indicates that RBP 
may help with nitrogen detoxification by transporting nitrite from the periplasm to the 
cytosol for conversion. 
In iron-limited conditions (Table 7), when the RBP gene is missing, five of the 
most down-regulated genes were ISPg3 or ISPg5 transposases. These IS elements have 
been shown to activate cryptic genes by appropriate juxtaposition of promoter sequences, 
or conversely, to inactive gene expression by insertional mutagenesis and could play a 
role in enhancing or promoting translational or transcriptional machinery potentially  
(Califano et al., 2000). Additionally, PG2213, a nitrite reductase-related protein was also 
down-regulated, thus slowing conversion of nitrite to NO. Conversely, two of the most 
up-regulated genes deal with iron or hemin binding, PG1505 and PG2034, and could 
indicate RBP’s direct role in hemin transport under iron-limited conditions. Additionally, 
translational machinery has also been up-regulated (PG1256), hinting once again that 
RBP could indeed enhance translation.  
Our last aim for this part of the project was to compare proteomics data between 
V3139 and W83 to determine whether proteins are differentially translated between the 
two strains. As RBP may work at the RNA or protein level, there is a possibility that 
RNA levels and protein profiles may differ. That is why proteomics analysis was also 
performed. Proteomics replicates were initially prepared in February, but because the 
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analytical machinery was down, we didn’t get results until months later. Unfortunately, 
the sample preparation protocol utilized used a detergent and gave poor results. Recently, 
another replicate was prepared and sent out for analysis but it has not yet been run. A 
protein gel, however, was run to visualize any protein band differences and is pictured in 
figure 31. Unfortunately, no obvious inferences can be made from just viewing the gel 
and proteomics results must be returned. 
Finally, a hypothetical model of the role of RBP in P. gingivalis was created 
based on RBP function across species as well as data analyses from all the studies 
discussed here. This is depicted in figure 32 and shows that RBP may play a role in either 
repressing or enhancing translation, or alternatively degrading target mRNA directly. 
Taken together, RBP may potentially work to alter RNA and/or protein levels, but more 
studies would need to be conducted to confirm or deny this claim. 
A second focus of this thesis is the characterization of four putative genes in 
response to environmental stress, PG0893, PG1421, PG1820, and PG1821. These four 
genes were chosen as sequences homologous to these in other species exhibited 
involvement in nitrosative and oxidative stress protection mechanisms. Mutants were 
attempted to be created as detailed in the “Material and Methods” and “Results” section, 
however, after months of electroporation, no viable mutants were discovered. First, up- 
and downstream regions of each gene were amplified via PCR, and a fusion PCR 
protocol was utilized to insert the ermF cassette into the gene, effectively knocking the 
gene out and instilling erythromycin resistance into the insert. Next, these PCR products 
were confirmed for size via restriction enzymes digestion (Figure 36) before they were 
utilized for electroporation. As I was unsuccessful to create a mutant deficient in any of 
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these genes, another lab member will need to continue the project going forward. It is 
possible that one or more of these genes is lethal to P. gingivalis when knocked out, but 
PG0893 was previously created though lost. Otherwise, non-optimal media broth or other 
various factors could account for why no mutant has thus yet been created. 
In conclusion, we were able to demonstrate that PG0627 is a good candidate for 
an RNA-binding protein, and that it’s biological characterization will help to further 
strengthen this hypothesis. We were able to show that PG0627 plays a role in the 
nitrosative stress protection mechanism in P. gingivalis, as well as in protease activity, 
virulence ability, hemin depletion, potential transport of iron and, somewhat, oxidative 
stress protection mechanisms. Further work must be done in order to confirm PG0627’s 
role as an RNA-binding protein, specifically it’s interactions with and affinity for RNA, 
and is a suitable project for another student to take over in our lab. 
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